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SUMMARY 
I Nucleoside deoxyribosyltransferase catalyses the transfer of a2- 
deoxyribose sugar between purine and pyrimidine bases. In 
nature, their occurence appears to be confined to selected lactic 
acid bacteria, notably those from the genus Lactobacillus. 
L. leichmannii possess two distinct nucleoside 
deoxyribosyltransf erases: N-deoxyribosyltransf erase -I, which 
mediates the transfer of the glycosyl group between purine bases 
exclusively, and N-deoxyribosyltransferase-11 which catalyses the 
transfer of the 2-deoxyribose sugar to and from purine and 
pyrimidine bases. 
These enzymes are capable of accepting a wide number of 
heterocyclic base analogues as substrates and the necessary 
structural requirements for a competent acceptor have been 
defined. Similarly, it has been established that the N- 
deoxyribosyltran sf erase enzymes possess relatively little 
tolerance towards substrates with modified sugar moieties. 
The transfer reaction proceeds via an enzyme -substitution or 
ping-pong . bi-bi mechanism and kinetic and radiolabelling 
experiments provide reasonable support for the existence of a 
covalent glycosyl intermediate. Chemical modification of N- 
deoxyribosyltransferase-11 with specific chemical reagents 
suggest that a histidine and, or carboxyl residues may participate 
in binding and catalysis at the active site of the enzyme. 
xi 
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' Yes, I have a pair of eyes, ' 
wos a pair o' patent double 
hextra power, p'raps I might 
stairs and a deal door; but 
limited' 
replied Sam, 'and that's just it. If they 
million magnifyin' gas microscopes of 
be able to see through a flight o' 
bein' only eyes, you see, my wisdom's 
The Pickwick Papers Charles Dickens (1812-1870) 
CHAPTER 1 
INTRODUCTION 
1.1 GENERAL BACKGROUND 
There are many different kinds of proteins in living systems 
most of which play crucial roles in maintaining the efficiency of 
biological processes. These macromolecules function in the 
mechanisms of motion, transport and storage, as major 
structural components, within the central nervous system, and 
as highly specific proteins which mediate immune response. 
But perhaps the most noteworthy class of proteins are enzymes, 
which catalyse the chains of chemical reactions comprising the 
pathways of metabolism. 
The elucidation of the structures and mechanisms of action of 
these proteins leads us to a general understanding of how 
enzymes function in nature and as chemical catalysts in vitro. 
It enables us to predict roles for specific enzymes in metabolism 
and allows an explanation of some of the quite extraordinary 
properties peculiar to these molecules, such as their 
exceptionally high rates of catalysis and a remarkable 
specificity towards certain ligands. 
Catalysis can be considered from several viewpoints. Indirect 
evidence of the mechanism by kinetic analyses provides 
information on the order in which substrates bind to the 
molecule how the products are released and the velocity at 
which these reactions occur. However, this fails to give any 
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detail of the structural elements involved and what specific 
groups participate in the chemistry of substrate binding and 
catalysis. Structural analysis, on the other hand, can convey a 
knowledge of both the overall three dimensional and subunit 
structure of the enzyme molecule in addition to the binding site, 
where specific amino-acid side chains and prosthetic groups 
may be involved in catalysis. 
Inferences about the specific nature of these groups involved in 
the catalytic mechanism and whether these functionalities 
interact directly with substrates and products or play roles in 
the secondary bonding and stabilization of reactants and 
intermediates, can be made from an investigation of substrate 
specificity and from the action of inhibitors and reagents which 
attack particular chemical groups. 
The key feature of the enzyme -cataly sed reaction, is that it 
occurs at a well defined binding site. This active site is a 
three-dimensional region in the enzyme constructed from 
amino-acids which may be from different parts of the primary 
sequence. 
The residues which comprise this active site can be catalytic or 
binding groups. The catalytic groups participate directly in the 
chemical changes at the site. Ligands with a particular affinity 
for the active site can bind reversibly to form an enzyme- 
substrate complex. These substrates are bound by relatively 
weak forces including covalent bonds, electrostatic attraction, 
hydrogen bonding, and hydrophobic affinity [1]. 
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The specificity for binding is dependent on the arrangement of 
residues in the site. Emil Fischer first explained the marked 
stereo specificity of enzymes in terms of a lock-and-key 
hypothesis [2]. Using a series of stereoisomeric sugars, 
glycosidase enzymes were imagined to have binding sites 
complementary in nature to their natural substrates. It was 
later observed that not all enzymes molecules possessed such a 
rigid structure which led to the proposal of the induced-fit 
model by Koshland [3]. The binding of a substrate was now 
envisaged to induce a change in protein conformation, leading to 
a structure optimal for catalysis. Release of the product then 
allowed the enzyme to revert to its original shape. Thus, the 
active site can be viewed as a dynamic system. 
APPLICATIONS 
An understanding of protein catalysts can also help to predict 
their potential usefulness as tools to assist in the development 
of synthetic procedures. Currently enzymes are playing major 
roles in certain industries and one of the most widely 
recognised uses of enzymes in industrial biotransformations is 
in the food industry. 
Enzymes are also widely used in agriculture and medicine, 
enhancing traditional processes or replacing expensive and 
time-consuming operations. In the pharmaceutical industry, 
the major product of enzyme technology is the production of 
semi-synthetic penicillins. In addition to their contribution in 
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the field of antibacterial medicine, they have also found 
application in the area of antiviral therapy. 
1.2 ANTIVIRAL THERAPY 
With the incidence of acquired immune deficiency disease 
(AIDS), increasing rapidly in the last five years, the search for 
new antiviral drugs has assumed new and much greater 
proportions. Not only is there a need for drugs to inhibit or 
prevent the replication of viruses, but in the case of the Human 
Immunodeficiency Virus (HIV), to treat the life-threatening 
opportunistic infections associated with this 
immunosuppressive condition [4,5]. 
Because the virus replicative cycle is intimately associated with 
the host cell biochemical Mechanisms, successful treatment 
requires the interuption of viral multiplication by specific 
inhibition of viral enzymes. Increasing knowledge of the virus 
structure and its life cycle, has enabled the identification of 
biochemical events and pathways unique to these parasites and 
made feasible the rational design of chemotherapeutic agents to 
combat and control viral infections [6-12]. 
There are several stages in the viral life cycle where drugs can 
be targetted, but the majority of current successes have 
centered around interrupting nucleic acid synthesis and most of 
the promising drugs have been nucleoside analogues [13,14,15v 
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161. Members of this class of compounds exhibit significant in 
vitro and in vivo antiviral activity. 
1.3 NUCLEOSIDE ANALOGUES 
Purine and pyrimidine nucleoside analogues have been 
developed as inhibitors of the replication of both DNA and RNA 
viruses [17,18,19,20,21]. These compounds inhibit DNA 
replication by mimicking the structure of natural nucleosides - 
the precursors of DNA and RNA. They can block viral 
replication by acting as chain terminators [21,22j or by acting 
as inhibitors of methylation reactions essential to the 
transcription of mRNA [18,23]. They can also become 
permanently associated with viral polymerases and bind to the 
terminated DNA template [24]. This last action renders the 
enzyme molecule incapable of further reaction. Thus, the role 
of these compounds is to prevent nucleic acid synthesis in the 
infected cell. The selective effect of these drugs often relies on 
the virally-encoded enzymes [25,26] which activate the 
nucleoside analogues and on the high affinity of the viral 
polymerase to the compound compared to the host cell DNA 
polymerase. 
The guanosine nucleoside analogue 9-(2-hydroxyethoxymethyl) 
guanine or acyclovir (1), [14,27] has proved to be very 
successful as a potent inhibitor of several viruses including 
those of the herpes simplex family; (HSV). 
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Dideoxynucleo side analogues such as 2', T-d ideoxyin o sine (M), 
(2), and 3'-azido-3'-deoxythymidine (AZT), (3) [20,21] can be 
metabolised by cellular enzymes to produce their triphosphates 
which, in turn, act as potent inhibitors of the retrovIral enzyme 
reverse transcriptase [7]. However, despite these successes, few 
antiviral drugs are currently in approved clinical use. and there 
is a great deal of interest in expanding the range of these 
clinically useful therapeutic agents. This demand has been 
heightened with the awareness of antiviral drug resistance [281. 
1.4 CHEMICAL SYNTHESIS OF NUCLEOSIDE ANALOGUES 
The production of nucleoside analogues by chemical means falls 
into two catagories: the modification of a preformed nucleoside 
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or the de novo synthesis of a novel nucleoside by the fusion of 
a sugar group with a base. 
(A) FUSION OF HETEROCYCLIC BASE AND SUGAR 
The most widespread methods of chemical nucleoside syntheses 
are those employing condensation reactions using protected 
base and sugar derivatives [29,30]. The Koenigs Knorr or 
heavy metal procedure employs salts of purines and 
pyrimidines together with a protected sugar halide. In the 
reaction of purines with the sugar group, the initial product is 
the N-3 glycosyl derivative. This then undergoes an 
intermolecular rearrangement to give the N-9-P -nu cleo side 
(Figure 1.1). With pyrimidines the first fusion product is the 0- 
glycoside derivative which rearranges to the final N-glycoside 
[30]. In the synthesis of deoxynucleosides however, anomeric 
mixture are produced. 
Like the Koenigs Knorr reaction, many of the traditional 
methods of synthesizing ribo- and deoxyribon uc leo sides also 
produce mixtures of the cc- and the P-anomers of the nucleoside 
analogue. Resolution of these isomers can result in a drop in the 
overall yield. Some stereochernical control can be gained in the 
synthesis of deoxynucleosides using suitable reaction conditions. 
In the synthesis of pyrimidine nucleosides using silylated 
heterocylic bases, judicious choice of solvent was observed to 
promote the formation of the natural P-anomer. Non-polar 
solvents such as carbon tetrachloride were used to good effect 
to increase the P/(x anomer product ratio. The use of an (x - 
bromo-sugar instead of a peracylated sugar in the synthesis 
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of deoxyribonucleosides has also led to the almost exclusive 
synthesis of the P-anomer of selected nucleoside analogues [311. 
Protection is often necessary to provide regioselectivity in the 
chosen modification. However, protection and deprotection 
adds more steps to the operation and the yields can be quite 
substantially reduced. 
(B) CHEMICAL MODIFICATION OF AN EXISTING NUCLEOSIDE 
There has been much interest recently in the synthesis of novel 
nucleosides containing unusual sugar moieties. Methods have 
been developed for the production of these compounds from 
preformed nucleosides by the chemical introduction of groups 
to generate the desired compound. The fluorinating agent 
diethyl amino sulphur trifluoride (DAST) has been employed 
with some success in this fashion in the chemical synthesis of 
3'-fluoro-2', 3'-dideoxynucleosides [211. Although the reaction 
of a range of different purine and pyrimidine 21- 
deoxyn ucleo sides give good to moderate yields of the 3'-fluoro- 
2', 3'-dideoxynucleosides these methods still require strict 
operating conditions in addition to the use of protecting agents, 
all of which result in reduced final yields. 
In the same way, the synthesis of nucleosides with unusual 
bases involves the introduction of substituents onto the 
heterocyclic base. 
These chemical methods have often proved laborious and 
complex. In view of this situation, it is possible to make use of 
some of the unique properties of enzymes, either in 
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combination with chemical steps to improve existing 
procedures, or to develop methods where the use of a 
biocatalyst obviates the need for many of these non-specific, 
multistep processes. Exploitation of the stereo- and 
regioselectivity of enzymes together with their ability to 
catalyse reactions under mild conditions, seem to suggest a far 
more amenable way to extend the range of potentially 
therapeutically useful compounds in this class. The use of 
enzymes in glycosyl transfer reactions leads exclusively to the 
P-anomer of the nucleoside and usually only one position on the 
heterocyclic base is glycosylated [32]. 
Methods using biocatalysts in these syntheses are relatively 
new compared to the traditional chemical processes and there 
are still disadvantages, especially with respect to the large-scale 
production of nucleoside analogues which often relies on 
substantial amounts of enzymes. Limited enzyme production in 
some species of microorganisms due to low biomass could be 
addressed to some degree with the use of genetic maniplulation 
to create mutants and over-producing strains. The use of 
immobilized whole cells or enzymes on a variety of supports 
could also prove to be preferable to manipulation of enzymes in 
batch culture [331. There also has to be some attention directed 
towards solving the problem of low solubility of some 
substrates and products in these enzymatic systems. 
The yields of these enzymatic reactions can still be relatively 
low, but a knowledge of enzyme stability and the optimal 
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operating conditions of specific enzymes can enable 
development of methodology to give respectable yields. 
In order to find a compound with good antiviral activity, 
thousands of drugs have to be screened. Much time and effort 
has gone into designing and synthesizing nucleoside analogues 
that might possess antiviral activity. Since many enzymes also 
accept analogues of their natural substrates, the capability for 
simple, rapid, small-scale synthesis of a broad range, of base- 
and sugar-modified nucleosides has become both feasible and 
attractive. Thus, by using enzymatic synthesis, perhaps part of 
the answer of how to make this screening operation more 
efficient can be found. 
1.5 ENZYMATIC SYNTHESIS NUCLEOSIDE ANALOGUES 
(A) ENZYMATIC MODIFICATION OF EXISISTING NUCLEOSIDE 
ANALOGUES 
Enzymes have had limited use as catalysts in the modification of 
existing nucleosides [34,351. One of the most useful 
applications has been in the resolution of racemic mixtures of 
nucleoside analogues with antiviral activity [36,37,38]. 
The production of racemates is one of the problems frequently 
encountered in chemical syntheses. In therapeutically active 
racernates it is of ten observed that one enantiomer is 
significantly more biologically active than the other. It 
therefore becomes important to obtain an isomerically pure 
preparation, not only in terms of efficacy, but also with regard 
to its safety. An example of this omission is highlighted in the 
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marketing of the drug thalidomide. Originally synthesized as a 
racemate, it was only after its neurotoxic affects became 
recognised that the isomers were examined. it was found that 
the teratogenic affects at least were restricted to the (-)-S- 
thalidomide. 
The potent anti-herpes nucleoside carbocyclic 21 -arabino-fluoro 
guanosine has been synthesized chemically to produce, in good 
yield, a mixture of active enantiomers. To determine which 
enantiomer had the maximum efficacy, the mixture was 
enzymatically resolved by enantioselective hydrolysis [38]. The 
preparation was initially monophosphorylated using phosphate 
and thymidine kinase from HSV-1 cells followed by treatment 
with 5'-nucleotidase from Crotalus atrox venom. This led to the 
selective removal of the 5 '-phosphate group from the 
dextrorotatory enantiomer. The relative rapidity of the reaction 
of the (+) enantiomer as compared to that of the (-) isomer was 
thought to be because of its resemblance to the natural 
substrate. 
A separate test of the two enantiomers against HSV-1 
demonstrated that the dextrorotatory isomer had twice as much 
biological activity as the original racemate, whereas the 
laevorotatory isomer exhibited a two-fold decrease. 
(B) ENZYMATIC SYNTHESIS OF NUCLEOSIDE ANALOGUES 
USING GLYCOSYL TRANSFER REAC71ONS 
Two classes of enzymes are used in the synthesis of nucleoside 
analogues; nucleoside phosphorylases and N- 
deoxyribosyltran sf erases 
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1.5.1 NUCLEOSIDE PHOSPHORYLASES 
The idea of using enzymatic processes to synthesize novel or 
unusual nucleosides is not a new one. The discovery of 
nucleoside phosphorylases and a description of their general 
mechanism made feasible the possibility that such a method 
could be used [39, 401. Found in a wide variety of mammals 
and microorganisms, [41,42,43] they have already shown 
themselves to be capable as competent biocatalysts in the small 
scale production of these compounds [44,45,46]. 
An extensive search has been made in diverse families of 
microorganisms [47] for an enzyme activity which has the 
ability to transfer ribose and 2'-deoxyribose groups from 
nucleosides to pyrimidine and purine bases. Cell-free extracts 
from almost all of the members of the family of 
Enterobacteriaceae and some strains from the genera 
Micrococcaceae, Bacilliaceae and Cornybacteriaceae were found 
to catalyse a ph o sphate -dependent transfer. Both pyrimidine- 
and purine-specific phosphorylases were reported. 
Revelations from substrate specificity studies using uridine and 
thymidine donors for the transferase reaction with extracts 
from several bacteria led to the proposal that two discrete 
pyrimidine phosphorylase enzymes existed. The participation 
of distinct purine and pyrimidine phosphorylases was verified 
by the purification of purine nucleoside phosphorylase - PNPase 
- (EC 2.4.2.1), uridine phosphorylase - URPase - (EC 2.4.2.3), and 
thymidine phosphorylase - TdRPase - (EC 2.4.2.4. ) from 
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Aerobacter aerogenes IFO 3321 [471. Probably best 
characterized are those from the enteric bacterium E. coli [48, 
49,50]. 
A general mechanism for PNPase was first proposed in 1945 
[39]. The nucleosidase was observed to act as a phosphorolytic 
enzyme, liberating purine bases and (x-D-ribose-I -phosphate 
from purine nucleosides. Since this was an equilibrium 
reaction, it meant that the addition of a new base to the system 
could generate a new nucleoside. This was demonstrated by 
incubating ribose- I -phosphate with hypoxanthine in the 
presence of nucleoside phosphorylase from rat liver. All of the 
hypoxanthine disappeared and was found as the hypoxanthine 
riboside. 
The mechanism was proposed to have proceded as follows: 
Base-ribose + 
3- Base+ ribose-l-P04 
3 P04 
Base* + ribose-l-PO Base*-ribose + P04 
3- 
4 
Where: Base = heterocyclic base; (purine or pyrimidine) 
Figure 1.2 
Thus, the reaction did not proceed in the absence of phosphate 
ions [40]. 
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There was also speculation that deoxyribon ucleo sides might 
participate in the same type of reaction. The formation of a 
deoxyribose-I -phosphate intermediate was demonstrated when 
thymidine was incubated with an extract derived from rat liver 
[511. This phosphorolysis was attributed to the action of a 
pyrimidine nucleoside phosphorylase. The reaction was then 
coupled to purine nucleoside phophorylase and, with the 
addition of hypoxanthine base, the 2'-deoxylnosine nucleoside 
was synthesized. The same intermediate has also been isolated 
from the phosphorylysis of purine deoxyribonucleos ides [52]. 
ENZYMATIC SYNTHESIS WITH NUCLEOSIDE PHOSPHORYLASES 
One of the first enzymatic syntheses of a nucleoside analogue 
employed crude extract from E. coli B cells [53]. The 
antimetabolite, 5 -trif I uromethyl-2'-deoxyurid in e (4) was 
produced in low yields by the exchange reaction between the 
pyrimidine base analogue, 5'-trifluoromethyluracil, and 
thymidine. Since the enzymatic conversion occurred only in the 
presence of inorganic phosphate, the exchange reaction between 
deoxynucleoside and base was assumed to have been mediated 
by phosphorylase enzymes. 
Since then nucleoside phosphorylases from a variety of sources 
have been engaged to make a wide range of analogues. 
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Whole cells from E. coli BM-1 1 have been used to synthesize 
enzymatically the antiviral compounds 5 -ethyl -(2-bromovinyl) - 
2'-deoxyuridine and (E)-5-(2-bromovinyl)-2'-deoxyuridine, 
(EDU and BVDU) [54]. The catalysis was performed by a 
combination of (TdRPase) and PNPase where either thymidine 
or 2'-deoxyguanosine functioned as the donor and (E)-5-(2- 
bromovinyl) uracil as acceptor. One problem was that of very 
low productivity of the BVDU. This was ascribed to the poor 
solubility of the bromovinyluracil base. The addition of DMSO 
to the mixture improved these figures quite considerably. 
The poor solubility of the nucleoside antibiotic and antiviral 
compound, guanine 7-N-oxide has led to efforts to improve its 
solubility, and hence activity, by preparation of its 
corresponding nucleoside guanosine 7-N-oxide. Wet cell paste 
from Bacillus subtilis catalyses the reaction between ribose-l- 
phosphate and guanine-7-N-oxide [55] and the activity is 
consistent with the action of PNPase. 
A variety of 3-deazapurine ribo- and deoxynucleosides have 
been prepared using the coupled enzyme system of TdRPase, 
URPase and PNPase purified from E. coli [45]. The initial 
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phosphorylation to produce the 2'-deoxyribonucleoside-l- 
phosphate was mediated by TdRPase, while the ribose-l- 
phosphate intermediate resulted from the action of UPase on 
uridine [Figure 1.3]. 
The broad spectrum antiviral compound 1-(P-D-ribofuranosyl)- 
1,2,, 4-triazole-3-carboxamide, (ribavirin, virazole), has also been 
prepared using phosphorylase enzymes [46]. 
A two-step reaction using purified purine nucleoside 
phosphorylase from Enterobacter aerogenes AJ 11125 has been 
used where the glycosyl donor was inosine and the initial step 
involved the production of ribose-I -phosphate from the 
enzymatic phosphorolysis of the purine nucleoside [461. The 
ribose-I -phosphate was isolated by ion exchange 
chromatography onto a column before it was combined with 
1,, 2,4-triazole-3-carboxamide (TCA). A transribosylation 
reaction then produced the nucleoside virazole. 
The rationale behind the method takes into account the 
relatively low affinity of the TCA for the purine nucleoside 
phosphorylase as compared to that of the hypoxanthine base. 
(Km-TCA, 167mM; Km-HX, 5.6mM) If the hypoxanthine was 
retained in the reaction, it would compete with the TCA for the 
enzyme, and hamper its chances of recognition as a competent 
substrate. 
A number of other bacteria have been tested for their ability to 
make virazole. Several were cited as producing good yields of 
either the ribose- I -phosphate intermediate, or the new 
nucleoside. In one study to increase the productivity of the 
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2'-Deoxyribonucleo sides with Pyrimidine and Purine 
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virazole reaction, a combination of microorganisms were used 
[561. The enzymes from Erwinia carotovora catalysed the 
phosphorolysis of inosine, and those from Bacillus brevis the 
ribosylation of TCA. This proved to be a more efficient and 
productive system than the one using Enterobacter aerogenes 
AJ 11125 alone. Whole cells of Erwinia carotovora can also use 
orotidine as a ribosyl donor in this reaction [57]. 
The avoidance of a system which requires the presence of both 
purine and pyrimidine phosphorylase enzymes, and the 
multistep procedure involving the isolation of the ribose-l- 
phosphate for glycosyl donation would serve to improve the 
simplicity of this enzymatic route. A method has been 
developed so that only PNPase is necessary for the efficient 
synthesis of purine nucleoside analogues [58]. Based on a 
proposal of how the phosphorylation step might occur at the 
active site, a 7-methyl-ribonucleoside donor has been designed. 
Its affect is to make the initial phosphorylysis essentially 
irreversible since the 7-methylpurine does not acts as a 
nucleophile in the reverse reaction [59]. The yields for 
producing compound such as 3-deazaadenosine and virazole by 
this method were very high. Thus, by exploiting the coupled 
nature of the enzymatic route,, synthetic procedure can be 
improved. 
In addition to phosphorylases being used as catalysts in the 
biotransformation of unusual heterocyclic bases with ribosyl 
and deoxyribosyl donor nucleosides, they have also been 
functional in the synthesis of nucleosides with modified sugar 
moieties [601. 
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Whole cells from several bacterial sources, including E. coli, 
Enterobacter aerogenes AJ 11125 and Erwina herbicola have 
been used in the synthesis of 2- amin o-2'-deoxyribo sides 
compounds, some of which have antibacterial, antiturnour and 
antiviral activity [611. When 2'-amino-2'-deoxyuridine was 
used as the glycosyl donor, in the presence of inorganic 
phosphate, the wet cell paste of the Enterobacter aerogenes AJ 
11125 transformed the purine bases adenine, hypoxanthine, 2- 
ch lorohypox an thine and guanine into their respective 21 -amino- 
2'-deoxyribonucleotides [62]. Since no reaction occurred in the 
absence of phosphate ions it is justifiable to assume that the 
transglycosylation is catalysed by nucleoside phosphorylases. 
Applying a combination of chemical and enzymatic techniques, 
2', 3'-dideoxyuridine has been used as a glycosyl donor with 
resting whole cells of E. coli AJ 2595 for the synthesis of the 
2', 3'-d ide ox ynuc leos ides of adenine and hypoxanthine [631. 
2', 3'-Dideoxythymidine could also be produced by this reaction. 
It was observed that the yields of the 2', 3'-dideoxyadeno sine 
reaction were significantly improved on the addition of 
polyethylene glycol, (PEG). It is possible that this helps to 
improve productivity in several ways. The PEG could help to 
stabilise the proteins, as well as aid in the permeability of the 
cells to the substrates. It could also assist in the dissolution or 
dispersion of the substrates, making them more available to the 
enzymes. 
P-D-Arabinofuranosyl nucleosides have also been synthesised 
using nucleoside phosphorylase enzymes. 9-(p -D- 
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Arabi nofuran osy 1) guanine is active against viruses of the 
herpes family and has been prepared with glutaraldehyde- 
treated cells from E. coli BM-11 [64]. This method uses 2- 
deoxyguanine as a source of guanine base, and 1 -(P -D- 
arabinofuranosyl) cytosine (ara-C) as the sugar donor. 
Trans arabinosylati on, via 1-(P-D-arabinofuranosyl) uracil (ara- 
U), is performed with reasonable efficiency to give modest 
yields. 2'-Deoxyguanosine was used as a substrate for PNPase 
to overcome problems of guanine base solubility. 
The stereospecific synthesis of the antiviral 9-(D -D- 
arabinofuranosyl) derivative of adenine (ara-A) [65], has been 
carried out with Enterobacter aerogenes AJ 11125 cells [461. 
The reaction was highly dependent on the concentration of 
phosphate in the incubation medium and appeared to exhibit 
maximum productivity when performed at 60-650C. The 
transformation was attributed to the combined action of URPase 
and PNPase in the absence of adenosine deaminase activity. 
This procedure takes advantage of the very low solubility of the 
product, allowing it to precipitate out, facilitating its easy 
isolation. The yield in this reaction was high; as much as six 
grams per litre. 
SUMMARY 
Purine and pyrimidine nucleoside phosphorylase enzymes have 
proved to be very useful biocatalysts in the preparation of 
moderate yields of nucleoside analogues. They are stable and 
have a wide substrate range [66,67]. with the exception of 
adenine intolerance in mammalian PNPase [681, and have been 
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shown to be useful tools of synthesis as both purified and crude 
extracts. 
The discovery of purine phosphorylase enzymes specific 
towards inosine and guanosine nucleosides, [50] and to adenine 
increases [691 the range of tools available to the chemist, and 
begs the question as to whether the range and potential of 
enzymes that could be accessible and well-suited to synthetic 
purposes have yet been realised. 
The major disadvantages of these reactions lie in the two stage 
nature of the mechanism and it is not uncommon to find that 
the rate of a reaction is severly limited by the differential 
specificities of the enzymes for a substrate. 
1.5.2 N-DEOXYRIBOSYLTRANSFERASES 
The view that these transglycosylation reactions proceeded via 
a coupled phosphorylase mechanism persisted until the 
discovery that the 2'-deoxyribose group of a natural nucleoside 
could be transferred directly to a heterocyclic base in the 
absence of phosphate ions using the extracts of certain lactic 
acid bacteria. 
This phosphate-independent transfer of the sugar moiety was 
first reported by McNutt in 1950 [70,71]. It was known that 
selected species of bacteria required deoxyribonucleosides for 
growth, notably members of the genus Lactobacillaceae, [72,73] 
and that any one of the four natural deoxyribonucleosides could 
serve equally well as growth promoting factors. It therefore 
seemed probable that the dependent organism converted the 
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administered deoxyribonucleoside to the other deoxyribose 
derivatives in order to make a full complement for nucleic acid 
synthesis. 
McNutt demonstrated that dialysed, and therefore essentially 
phosphate-free, extracts from Lactobacillus helveticus 
performed the trans glycosyl ation reaction when incubated with 
deoxyribonucleoside and a free purine or pyrimidine base [711. 
Contrary to expectation, deoxyribose-I -phosphate did not 
participate in this reaction. When it was employed as a glycosyl 
donor, with a variety of acceptor bases, no appreciable 
deoxyribonucleo side was produced. Preparations of two other 
strains, L. acidophilus and L. delbrueckii, were also found to 
catalyse the exchange. The enzyme was proposed to be acting 
as a trans-N-glycosidase. 
Since the reaction proceeded in the absence of inorganic 
phosphate, there was no evidence to suggest that nucleoside 
phosphorylases played any role in this transfer of the 
deoxyribose moiety. 
The discovery that the mechanism did not involve a 
phosphorylated intermediate, led to the speculation that the 
reaction mechanism involved an initial hydrolysis of the 
glycosidic bond followed by resynthesis to give the new 
nucleoside rather than the product arising from trans-N- 
glycosylation. Comparison of the rates of hydrolysis of the 
donor nucleoside and transfer to produce a new nucleoside 
dismissed this hypothesis of an primary hydrolysis step before 
resynthesis [711. 
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Another possibility was that the transfer involved secondary 
enzymes. There was a chance that, in the reaction of 2- 
deoxyinosine and adenine, 2'-deoxyadenosine was produced not 
by trans-N-glycosylation but by a transamination reaction 
involving the 6-position of the inosine donor. That this was 
untrue was verified by performing this reaction using 14C - 
radiolabelled adenine in the 8-position [74]. It was observed 
that the hypoxanthine formed was totally devoid of the 14C 
label and that the radioactivity lay exclusively in the adenine 
nucleoside formed. Thus, the transglycosidase mechanism was 
confirmed and the order of the reaction was depicted as follows: 
Base, -dRibose + Base2 Base2-dRibose + Base, 
Where: base = heterocyclic base; (purine or pyrimidine) 
dRibose = 2'-deoxy-o-D-ribose 
Figure 1.4 
An extensive search was carried out to investigate the 
occurrence of the N-deoxyribosyltransferase enzymes. A wide 
range of microorganisms and animal tissues were examined, but 
the activity was reported to have a limited distribution. It 
appears in high levels only in bacteria from the genus 
Lactobacillaceae which lack significant levels of nucleoside 
phosphorylase enymes [75]. 
N-deoxyribosyltransferases have been purified 
purified from a number of Lactobacillus [76-811. 
or partially 
The physical 
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and kinetic properties [82,83] as 
these enzymes have been invesi 
synthetic bi otran s formations has 
have been employed as whole 
purified extracts in the enzymatic 
nucleosides [32,84,85]. 
well as the substrate range of 
igated. Their suitability for 
also been tested and they 
cells and crude or partially 
syntheses of unusual or novel 
The N-deoxyribosyltransferase activity from L. helveticus was 
the first to be studied in detail. Investigations by Roush and 
Betz [80] provided preliminary information on the enzyme 
finding it to be stable to heat and to possess a tolerance towards 
a narrow range of acceptor bases. In confirmation with earlier 
studies, there was no evidence for nucleoside phosphorylase 
activity - the rates of reaction, the same in the presence or 
absence of inorganic phosphate, were consistent with its 
absence. They did, however, observe the very important 
differential inhibition of transfer activities in Tris buffer. The 
transfer of the deoxyribosyl sugar group to and from 
pyrimidine bases was strongly inhibited by the Tris, whereas at 
the same concentration the transfer to and from purine bases 
was only weakly affected. This observation was indicative of 
two distinct enzymes in the partially purified preparation. 
This proposal was confirmed by Holguin and Cardinaud [81] 
who were the first to demonstrate the existence of two discrete 
N-deoxyribosyltransferase activities in L. helveticus. The two 
enzymes were separated by affinity chromatography using a 
derivatized purine nucleoside analogue as a ligand. 
N-deoxyribosyltransferase-I catalysed the transfer of the 
deoxyribosyl moiety to and from purine base exclusively, 
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whereas exclusively N-deoxyribosyltransferase-II transfered 
the sugar group to and from purine and pyrimidine bases 
(Figure 
N-d eoxyribosyltransf erase -I 
Purine-dR + Purine* Purine*-dR + Purine 
N-d eoxyribosy I trans f erase - 11 
Purine-dR + Purine* `NU- Purine*-dR + Purine 
Purine-dR + Pyr 
Pyr-dR + Pyr* 
Where: Pur = Purine 
Pyr Pyrimidine 
dRib 2-deoxy-D-ribose 
Figure 1.5 
Pyr-dR + Purine 
Pyr*-dR + PYr 
The two enzymes showed different physical properties and 
disparate inhibition towards Tris buffer. 
The trans de ox yrib os yl ati on has also been described in 
Lactobacillus leichmannii [78,791. The enzyme from L. 
leichmannii was observed to be capable of all types of transfer 
activities, independent of the concentration of the phosphate 
ions present. However, unlike L. helveticus, only one enzyme 
was identified [78,79,85]. Detailed kinetics of this transfer 
mechanism were investigated by Danzin and Cardinaud using 
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purified extracts of N-deoxyribosyltran sf erase from L. 
helveticus [82,83]. It was established that the reaction 
proceeded via a double -displacement ping-pong bi bi 
mechanism, where the first product is released before the 
second substrate binds to the enzyme. These results satisfied 
the criteria set out by Cleland to characterize such a pathway 
[861. 
The following scheme depicts the release of the base from the 
nucleoside donor, prior to the entry of the acceptor base into 
the active site (Figure 1.6. ). 
Base-l-dR Base-1 Base-2 Base-2-dR 
E-dR 
Figure 1.6 
This route suggests the formation of a glycosyl intermediate, 
[87] but as yet this hypothesis has not been confirmed. The 
substrate specificity of these transferase enzymes have also 
been tested [881. A wide range of heterocyclic bases have been 
found to act as competent acceptors, but extensive modifications 
in the sugar moiety are not tolerated. An attempt has also been 
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made to assign a function for the N-deoxyribosyltransferase 
enzyme in the general metabolism of Lactobacilli. 
FUNCrION OF N-DEOXYRIBOSYLTRANSFERASE ACTTVITY AND 
REPRESSION CONTROL 
The metabolic function of N-deoxyribosyltransferases is thought 
to be intimately associated with nucleic acid synthesis [89,901. 
It was already known that some species of bacteria required 
exogenously supplied deoxyribonuc leo sides for growth, but it 
was found that in L. leichmannii this demand could be satisfied 
by the supply of vitamin B12 [91]. 
When vitamin B12 is absent in the growth medium of L. 
leichmannii, the synthesis of a full set of DNA precursors is 
dependent on the catalysis by N-deoxyribosyltransferase of 
deoxyribose groups from the administered deoxyriboside to 
free bases. Three other species of Lactobacillus where N- 
deoxyribosyltransferase activity is found display a growth 
requirement like this; L. lactis, L. acidophilus and L. delbrueckii. 
However, only L. leichmannii and L. lactis have the ability to be 
alternatively nourished with vitamin B12 [73,92,93]. 
Starvation of vitamin B12 or deoxyribonucleoside is found to 
result in impaired DNA synthesis [91,94]. Under these limiting 
conditions the levels of N-deoxyribosyltransferase activity were 
observed to rise significantly, concurrent with a fall in the 
levels of the intracellular deoxyribosyl pool. Elevated levels of 
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enzyme with diminishing deoxyribosyl concentration implies 
that the enyzme synthesis is controlled by feedback inhibition. 
Whether this repression is dependent a specific combination of 
deoxyribosyl residues or one single type is unclear. 
The enzyme and vitamin B 12 are thought to have 
complementary role in nucleic acid synthesis (Figure 1.7). 
Purines and Pyrimidines D eoxyribon uc leos ides 
De Novo Preformed free purines and pyrimidines 
y 
N-deoxyribosyltransf erase 
t [Vit B 12] T 
Ribonucleotides Deoxyribonucleotides 
if 
RNA DNA 
Figure 1.7 
a 
Vitamin B 12 participates in the reduction of ribonucleotides to 
deoxyribonucleotides [95]. Thus, the biological function of N- 
deoxyribosyltransferase is to provide a complement of 
deoxyribonucleotides to fulfil the demands of the cell for DNA 
synthesis in the absence of Vitamin B12. 
L. leichmannii seem to favour using their deoxyribonucleo sides 
for the synthesis of deoxyribonucleotide triphosphates in 
contrast with certain enteric bacteria such as E. coli which 
prefer to catabolize their deoxyri bon ucleo sides. Perhaps this is 
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why Lactobacillus do not possess catabolizing enzymes such as 
deoxyriboaldolase, and the nucleoside phosphorylases TdRPase 
and PNPase- 
N-DEOXYRIBOSYLTRANSFERASES IN TTIE SYNTHESIS OF 
NUCLEOSIDE ANALOGUES 
N-deoxyribosyltransferase has shown itself to be a useful 
alternative to using nucleoside phosphorylase enzymes as 
biocatalysts in the preparation of nucleoside analogues. Extracts 
from several Lactobacilli have been used in these preparations 
[84,851. For the purpose of synthesis, the two transferase 
activities are not usually separated, but used as a relatively 
cru e mixture. 
N-deoxyribosyltransf erase from L. leichmannii has been 
instrumental in the synthesis of a number of both base- 
modified and sugar-modified nucleoside analogues. A diverse 
range of bases were observed to be competent acceptors for the 
enzyme and were used with thymidine as a glycosyl donor in a 
biotransformation reaction to synthesize a sequence of 2- 
deoxyadenosine nucleoside analogues [85]. The analogues were 
able to be produced on a scale of 100-400mg with an average 
yield of 64%. The good thermal stability of the enzyme 
preparation was exploited to the advantage of the preparation. 
9-p-D-2'-Deoxyribofuranosyl I-deazapurine has been prepared 
from crude extract of L. leichmannii with thymidine as a 
glycosyl donor [32]. This synthesis confirms the high degree of 
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regio- and stereoselectivity that the enzyme conveys on the 
reaction. In both circumstances the glycosyl group is transfered 
exclusively to the N-9 postion on the purine acceptor, and the 
glycosidic link of the new deoxynucleoside shown to have the 0- 
configuration. 
The broad substrate specificity of L. helveticus has been 
exploited in the synthesis of a series of 2-deoxy-2-halopurine 
compounds [96]. Partially purified extract was incubated with 
thymidine and 2-halopurine acceptor bases to achieve the 
facile, large scale preparation of these anti-leukemic analogues 
[97]. An interesting property of these 2-halopurine nucleosides 
is their ability to resist the action of adenosine deaminase [85]. 
This observation was used later in designing the antiviral 2- 
halo - 2', 3'-dideoxynucleoside analogues [98]. 
The efficacy of the potent antiviral drugs 2', 3'- 
dideoxyaden o sine and 2', 3'-dideoxyinosine [99] are diminished 
inside cells by attack from adenine dearninase and mammalian 
PNPase respectively. 2-Hal o-2', 3'-dideoxyadeno sine derivatives 
are found to be resistant to this catabolism, and a combination 
of chemical and biocatalytic steps have been used to make these 
compounds. N-Deoxyribosyltransferase extract from L. 
helveticus was used in the direct and simple synthesis of 2- 
halo- 2'-deoxyadenosine nucleosides. Chemical methods were 
then used to produce the corresponding 2-halo -2', 3'- 
dideoxynucleosides. 
N-deoxyribosyltransferase is also able to accept some modified 
sugar groups in donor nucleosides. 2', 3-Dideoxynucleosides, 
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several of which have shown to be very potent inhibitors of the 
HIV-1 virus, have been prepared by enzymatic 
trans glycosyl ation using partially purified extract from L 
helveticus [100]. 
2', 3'-Dideoxycytidine acted as the pentosyl group donor to a 
variety of 2- and 6-substituted purine acceptor bases. The 
substrate specificity of acceptor bases in this reaction with the 
2', 3'-dideoxyribose moiety seems to be analagous to the 2'- 
deoxyribose transfer system. 
The ability of the N-deoxyribosyltransferase to accept the 2', 3'- 
dideoxyribosyl group as a substrate has led to its use in the 
very specific synthesis of sugar- and base-radiolabelled 
nucleosides for routine use in the analysis of drug metabolism 
of therapeutic nucleosides [53,85]. 
SUMMARY 
N-deoxyribosylransferases have been shown to be practical in 
the synthesis of a number of nucleoside analogues. The 
enzymes are able to accept a large number of different 
I unnatural' substrates with modifications both in the sugar and 
the heterocyclic base. 
Some of the problems which arise from using phosphorylases in 
a coupled, ph osph ate -dependent system for these 
biotransformations can be overcome with N- 
deoxyribosyl tran sf erases. 
With one reported exception [75], all members of the 
Lactobacilli family have a N-deox yri bosy I trans ferase activity 
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all of which catalyse the glycosyl transfer between purines and 
pyrimidines. In this respect they seem to possess some 
advantage over the phosphorylase system which generally 
relies on the presence of both purine- and pyrimidine- specific 
enzymes. 
Further study of the substrate specificity of these and other 
strains of the Lactobacilli genus and members of other genera 
of lactic acid bacteria could help to reveal enzymes which can 
use highly modified sugars as substrates in the transfer 
reaction. Characterization of the specific activities which 
perform these transformations will enable them to be used in 
circumstances where very selective catalysis is required, such 
as the removal or addition of particular groups to an existing 
molecule or the resolution of enantiomers. 
Information about the physical properties of enzymes and the 
way they behave outside of the living cell could enable the 
improvement of the stability of these biocatalysts and hence 
boost the yield of enzymatic syntheses [101]. 
Knowledge of the high thermal stability of the N- 
deoxyribosyltransferase extract from L. leichmannii has enabled 
this property to be exploited in the synthesis of certain 
compounds [851. 
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L6 OBJECTIVES 
The objectives of this project were to obtain a greater 
understanding of the N-deoxyribosyltransferase reaction in 
L. leichmannii. The active site was mapped by examining its 
substrate specificity in order to determine the nature and 
stereochemistry of binding. 
Chemical modification using group-specific reagents was used to 
reveal which amino-acid residues might participate in binding 
and catalysis. 
To date, studies on L. leichmannii have not revealed the 
existence of two discrete enzymes analogous to those of L. 
helveticus. We hoped that by the development of a different 
purification scheme we could demonstrate the presence of 
further enzymes. 
1.7 PROPOSALS FOR THE ACTIVE SITE OF GLYCOSYL 
TRANSFER ENZYMES 
Models for the active site of both phosphorylase and N- 
deoxyribosyltransferase enzymes have been proposed [102, 
103,104]. 
Detailed studies of subtrate and inhibitor of PNPase from 
mammalian and bacterial sources have led to the proposal that 
particular amino acid residues are in or close to the active site 
and play a big role in binding and catalysis. 
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Mammaliam PNPase is imagined to contain essential histidyl 
[1051 and carboxyl residues (Figure 1.8), which interact with 
positions 0(6) and N(l) on the six-membered ring of a purine 
base or nucleoside respectively. 
NI Histidyl 
N% 
H 
0 
H. 
NN Purine base 
HH P'O" 
p1 0-0, c% \-Ooe C-, 
H0 --------- 
H 
Carboxyl 
Figure 1.8 
On the basis of substrate specificity studies in L. helveticus [881, 
Holguin proposed that the imidazole ring of the purine base was 
essential for binding (Figure 1.9). 
NH2 
N 
A ok% 
Figure 1.9 
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CHAPTER 2 
PURIFICATION OF N-DEOXYRIBOSYLTRANSFERASES 
FROM 
L. LEICHMA NNII 
2.1 GENERAL BACKGROUND 
In order to study individual enzymes in detail they must be pure. 
Isolation of an enzyme from all other proteins and from 
polysaccharides enables conclusive results to be obtained in the 
investigation of the biocatalysis of one particular chemical 
reaction. Only when a reaction is catalysed by a pure preparation 
can it be said to be mediated by a single enzyme. The products of 
a reaction can also be substrates for other enzymes and it is 
essential to make sure that none of these are degraded or 
derivatised by contaminating proteins. 
The first successful enzyme purification was in 1926 when 
Sumner crystallized the protein urease [105]. There followed a 
period of investigation which concentrated on characterizing 
crystalline proteolytic enzymes, work which served to dispel any 
doubt that enzymes were indeed proteins. A large number of 
both intracellular and extracellular enzymes have now been 
purified, and although some have been found to require non- 
protein co-factors, each one has proved to be a protein. The 
purification of some enzymes has enabled their detailed 
characterization, both as chemical catalysts in isolation, and as 
components of the metabolic mechanism of the living cell. 
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N-Deoxyribosyltransferase enzymes from a number of different 
species of Lactobacillus have been purified (Table 2.1). 
The early approaches to the purification of N- 
deoxyribosyltransferases were relatively crude, consisting solely 
of salt fractionation and heat denaturation steps [76,77,80]. The 
extent of purification of the these enzymes was not outstanding 
and final preparations were always mixtures of the three transfer 
activities: 
(a) dPurl + Pur2 -- --"- dPur2 + PUrl 
(b) dPur + Pyr -- -- dPyr + Pur 
(c) dPyr, + Pyr2 ' dPyr2 + Pyr, 
Lactobacillus are generally grown in adapted, complex media, for 
example, De Mann, Rogosa, Sharpe (MRS) medium [106] which is 
designed for the profuse growth of lactic acid bacteria. The cells 
are grown without aeration and agitation and harvested in the 
stationary phase. After harvesting the biomass, the first stage of 
purification involves the homogenization of the cells. This entails 
disrupting the cells to release the cellular contents, including 
enzymes, into solution. There are many approaches to this 
problem from gentle enzymatic proteolysis of the cell walls with 
enzymes such as lysozyme [107] and mutanolysin [108] which 
produces protoplasts, to more vigorous techniques like sonication, 
or passage through a french pressure cell which breakdowns cells 
by shear forces. The most popular methods to disrupt the 
Lactobacillus cells have employed sonication [79,81,89] and 
bead-milling [76,801. After disintegration, the cell debris of the 
37 
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homogenate is removed by centrifugation. 
Since large volumes are generally involved, the concentration of 
the crude extract by salt fractionation is commonly the next step. 
This procedure allows large quantities of material to be dealt with 
and proteins are generally precipitated with ammonium sulphate. 
Bacterial extracts derived from vigorous disruption procedures 
such as sonication or passage through a pressure cell can appear 
viscous due to the presence of DNA. This accounts for the use of a 
second precipitation step with protamine sulphate in order to 
eliminate nucleic acid material [81,82,85]. The inclusion of heat 
denaturation steps in some purification methods exploits the 
property of the high thermal stability of some N- 
deoxyribosyltransferase activities. This was used routinely in 
earlier procedures before any detailed physical characterization 
of the activities [79,80]. These classical methods have remained 
important in the preliminary stages of the purification of these 
enzymes because of their ability to cope with reasonable amounts 
of extract and their relative insensitivity to any non-protein 
contaminants. 
Ion exchange chromatography was introduced in later N- 
deoxyribosyltransferase purification schemes [79,811. This 
adsorption column chromatography step separates protein 
molecules on the basis of their net charge at a given pH. Proteins 
bind reversibly to an insoluble ion-exchange matrix by 
electrostatic forces which exist between surface charges of the 
proteins and charged groups on the support. Salt gradients are 
the most common way of eluting proteins adsorbed to ion 
exchange matrices, although raising and lowering the pH of the 
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eluting buffer can be employed to the same effect. 
Initial attempts to purify discrete activities from L. helveticus 
using a combination of precipitation and ion exchange steps were 
somewhat successful allowing a partial separation of the 
purine: purine activity on a DEAE-Sephadex support [811. Affinity 
chromatography using a modified purine analogue as a ligand was 
required for the complete isolation of this activity [82]. This 
affinity adsorption technique aims to exploit the unique 
properties of individual enzymes on the basis of their biological 
specificity. Ligands, usually substrate analogues and competitive 
inhibitors of the desired enzyme, are covalently attached to a 
support so as to be available for selective combination with the 
protein of choice. This method requires that the affinity of a 
ligand for the enzyme is very high and that the binding is non- 
reactive and reversible. Affinity adsorption methods have also 
been employed in the purification of the N- 
deoxyribosyltransferase activities from L. leichmannii [851. 
Gel permeation or molecular exclusion chromatography, which 
has the least capacity of all the column techniques, separates 
proteins on the basis of molecular size and shape. This is 
normally employed as the final step in a purification. 
Hydroxyapatite, a form of calcium phosphate, has also proved 
itself to be useful in the fractionation of proteins. Its mode of 
action is not clear, but the surface of the matrix is made up of 
charged ions, and electrostatic attraction is thought to be 
important in the selective adsorption of proteins. Since positive 
and negative charges are closely associated in the support, the 
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binding is likely to arise from dipole-dipole interactions rather 
than any ion exchange effects. Although it has not previously 
been used in the purification of N-deoxyribosyltransferases, we 
decided that it might be a valuable complement to other 
separation methods. 
Our purification procedure has centred on trying to develop a 
suitable route to isolate the purine-specific N- 
deoxyribosyltransferase activity in L. leichmannii analagous to 
that from L. helveticus. 
2.2 MATERIALS AND METHODS 
2.2.1 Analytical Methods 
Unit ot enzyme Activity. 
A unit of activity is defined as the amount of protein which 
catalyses the formation of I. Ommol of 2'-deoxyadeno sine in 
one minute at 400C. 
Assay ot N-D eoxyribosyltra nsLe rase activity by HPLC. 
Deoxyribosyl transfer between purines was assayed routinely 
by measuring the formation of 2-deoxyadenosine from 2'- 
deoxyinosine and adenine at 400C using HPLC. The reaction 
mixture contained O. Igmol 2'-deoxyinosine, O. Igmol adenine, 
25gmol of Pipes buffer, pH 6.5, in a volume of 0.25 ml. The 
reaction was initiated by the addition of approximately 2 
milliunits (mU) of enzyme. At intervals of 10 minutes, samples 
(20gl) of the reaction mixture were injected onto a Lichrosorb 
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C 18 reverse phase column (Jones Chromatography, Hengoed, 
U. K. ) The nucleosides and bases were readily resolved by 
elution with a 15% aqueous solution of methanol and detected 
by absorbance at 254nm. 
Transfer reactions between other pairs of nucleosides and 
bases were assayed under similar conditions. Pyrimidine: 
purine transfer was assayed by monitoring the formation of 2'- 
deoxyadenosine from 2'-deoxycytidine and adenine. 
Pyrimidine: pyrimi dine deoxyribosyltransfer activity was 
assayed by following the formation of thymidine from 2'- 
deoxycytidine and thymine. 
Assay of N-DeoxvribosyltransLerase activity by Diphenylamin 
Colour Reaction. 
Deoxyribosyltransfer between purines and pyrimidines was 
assayed by measuring the concentration of free 2'-deoxyribose 
in solution using diphenylamine reagent [109). Commercial 
diphenylamine was recrystallized from petroleum ether. The 
colour reagent was prepared by dissolving lg diphenylamine in 
100ml glacial acetic acid and adding 3ml of sulphuric acid 
(1 8AM). This solution was kept at 40C. Two volumes of 
reagent were added to one volume of the standard assay 
mixture and incubated at 370C for 2 hours. The blue colour 
which appeared was measured spectrophotometrically at 
595nm. 
Assay of D eoxvribosvltra nsLe rase activity coupled to Xanthine 
Oxidase. 
A coupled spectrophotometric assay [1101 was employed for 
42 
sensitive measurements, i. e. the determination of apparent Km. 
In the measurement of the Km values for adenine, xanthine 
oxidase was used as an auxiliary enzyme. The hypoxanthine 
formed was rapidly oxidized to uric acid by the xanthine 
oxidase and the reaction followed by recording the absorbance 
change at 290nm (F-290 for uric acid was taken as 12,200 M-1 
cm-1). All reactions were carried out at 400C in a quartz 
cuvette of 10mm path length (final volume 1.5ml). 21- 
Deoxyinosine solution was mixed together with 50gmol of Pipes 
buffer, pH 6.5 and 3 mU units of xanthine oxidase. The mixture 
was equilibrated at 400C for 10 minutes to ensure that any 
trace amounts of hypoxanthine in the 2'-deoxyinosine were 
completely oxidised. The adenine was added and the increase 
in absorbance due to the slow oxidation of the base recorded. 
The enzyme solution (10mU) was added to start the reaction 
and the absorbance change followed with time. 
Protein Determination 
Protein determinations were carried out using the Bio-Rad 
protein assay according to the method of Bradford [111,112]. 
Bovine serum albumin was used as a standard. 
DH Optimum 
The enzyme was incubated under the standard conditions for 
20 minutes in OAM buffer at various pH values. Citrate- 
phosphate buffer was used in the range from pH 3.0 - 7.0, and 
phosphate buffer in the range from pH 6.0 - 8.5. 
43 
2.2.2 Cultivation of Organism. 
L. leichmannii ATCC 4797 were grown in a modified MRS 
medium [106]. Dehydrated MRS medium was dissolved in 20 1 
distilled water (26g 1-1) to give half the recommended 
concentration. The medium was adjusted to pH 6.5 with 5M 
NaOH solution and sterilized by autoclaving at 1210C for 50 
minutes. A solution, of 200g of glucose and 100g of 
bacteriological peptone was sterilized separately by autoclaving 
at 1100C for 10 minutes and added asceptically to the broth. 
The medium was inoculated with 200ml of a 16h starter 
culture grown in MRS broth, and incubated at 370C, without 
aeration or agitation. Growth was monitored by following the 
decrease in pH and the increase in optical density at 600nm. 
The bacteria were harvested in the stationary phase after 23 
hours of growth. The bacterial suspension was concentrated to 
II in a continuous centrifuge (American Instrument Company) 
then harvested by centrifugation at 17,700g for 15 minutes. 
The pellet was resuspended and washed twice in equal 
volumes of 0.02M Pipes buffer, pH 6.5, and stored at -200C as a 
cell paste. 
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2.3 RESULTS 
2.3.1 PURIFICATION PROCEDURE 
Preparation of Cell-& e Extract 
The paste was thawed and resuspended at a concentration of 
Ig ml-1 in 0.02M Pipes buffer, pH 6.5 containing 5mg ml-1 
lysozyme and 50 Uml-1 mutanolysin to digest the cell walls 
[108]. The preparation was incubated at 370C for 3 hours and 
protoplast formation was followed by light microscopy. 
Disruption was completed by two passages through a French 
pressure cell (American International Company, Maryland, 
USA. ) at 20,000 psi, and the preparation cooled to 40C in an ice 
bath. All subsequent operations were carried out at this 
temperature unless otherwise indicated. Cell debris were 
removed by centrifugation at 18,000g for 20 minutes. The 
pellet was resuspended in 0.02M Pipes buffer, pH 6.5, and 
subjected to two further passages through the pressure cell, 
then centrifuged under the same conditions. The supernatant 
fluids were pooled and assayed for nucleoside 
deoxyribosyltransferase activity. 
Ammonium SulDhate Precinitation 
The crude extract was fractionated by the addition of solid 
ammonium sulphate. The material precipitating between 40- 
80% saturation was collected by centrifugation at 38,000 g for 
25 minutes. This was dissolved in 0.02M Pipes buffer, pH 6.5, 
and dialysed against lOmM B is -Tri s/imin odi acetic acid buffer, 
pH 7.0. 
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Fast Protein Liquid Chromatography (FPLC) 
Anion Exchange on MON 
The dialysed material was applied to a Mono-Q high resolution, 
anion-exchange column (100 x 10mm) pre-equilibrated with 
lOmM Bis-Tris/iminodiacetic acid buffer, pH 7.0, and eluted 
with a linear 0-0.35M NaCl gradient in the same buffer. The 
gradient was run at 4ml min-' for 54 min. Eluant fractions, 
(5. Oml), were assayed under standard conditions. Enzyme 
activity appeared in two, partially separated, peaks eluting 
between 0.21 and 0.33M NaCl. The active fractions were 
pooled and dialysed against 10mM phosphate buffer, pH 6.0. 
DEAE-2SW 
This dialysate was applied to a TSK DEAE-cellulose 2SW column 
(7.8 x 300mm) which had been equilibrated with 10mM 
phosphate buffer, pH 6.0. The column was eluted at Iml min-' 
with a linear 0-0.5M NaCl gradient over 100 minutes. Eluant 
fractions (2. Oml) were assayed under standard conditions. 
Enzyme activity was resolved into two distinct peaks: IV(A), 
eluting between 0.3 - OAM NaCl and IV(B) between 0.4 - 0.5M 
NaCl (Figure 2.6). Most of the active fractions of each peak 
were pooled as fractions IV(A), N-deoxyribosyltransferase-I, 
and IV(B), N -deoxyribos yltran sf erase -11, and 
dialysed 
separately against lOmM phosphate buffer, 0.3mM CaC12, 
0.05% NaN3, pH 6.8. 
Hydroxyapatite-HPHT 
The dialysed fractions of N-deoxyribosyltransferase-1, IV(A), 
and N-deoxyribosyltransferase-11, IV(B), activity were applied, 
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in turn, to a Bio-Gel Hydroxyapatite HPHT column (Bio-Rad. ) 
(7-8 xlOO mm) and eluted at 0.5 ml min-' with a linear 
gradient of 0.01-0.4M phosphate buffer, O. ImM CaCl2,0.05% 
NaN3,, pH 6.8 (Figures 2.7[i] and 2.7[ii]). Eluant fractions were 
assayed under standard conditions and the active fractions 
pooled and dialysed against 10mM phosphate buffer, pH 6.0 to 
give fractions V(A) and V(B). 
Gel Filtration Chromato 
Pooled fractions V(A) and V(B) of each enzyme were loaded 
individually onto a TSK G4000SW gel filtration column 
(ToyaSoda, Tokyo, Japan) (7.8 x 300mm) and eluted with 
lOmM phosphate buffer, pH 7.0. The elution of the activities 
was followed by the assay of eluant samples under the 
standard conditions. There was insufficient protein in the 
recovered samples of VI(A) and VI(B) to carry out accurate 
determinations of specific activity. However, the samples were 
used to determine the molecular masses of the enzymes. 
Native-PAGE 
The purity of N-deoxyribosyltransferase-11 was confirmed by 
native polyacrylamide gel electrophoresis (native-PAGE) using 
the Phastsystem method developed by Pharmacia. 
5ng (approximately) of sample VI(B) was loaded onto a Phast Gel 
gradient 10-15 with Pharmacia molecular weight markers 
comprising a mixture of proteins in the range 67,000-669,000. 
The gel was run against native agarose buffer strips and silver 
stained according to the method set out by Pharmacia [1131. 
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Table 2.2 
Purification of N-deoxyribosyltransferase activities 
from Lactobacillus leichmannii 
Transfer between Purines 
I Crude Extract 
Il Ammonium Sulphate 
III FPLC Mono-Q 
IV HPLC DEAE 2SW (A) 
(B) 
V Hydroxyapatite (A) 
(B) 
Protein Activity 
M. & U Sp. Act Purif. Yield% 
[dl/Ade] 
1404 120.9 0.086 1.00 100.0 
767.1 78.0 0.102 1.19 64.5 
97.2 29.3 0.30 3.50 24.2 
9.10 23.0 2.52 29.3 19.0 
0.16 1.37 8.50 99.5 1.40 
0.70 12.5 17.85 207.6 10.3 
0.03 0.268 8.90 103.8 0.22 
Transfer between Purines and Pyrimidines 
I Crude Extract 
II Ammonium Sulphate 
III FPLC Mono-Q 
IV HPLC DEAE 2SW (A) 
(B) 
V Hydroxyapatite (A) 
(B) 
Protein Activity 
M-g S12. Act Purif. Yield 
[dC/Adel 
1404 301.0 0.21 1.00 100 
767.1 178.5 0.23 1.10 59.3 
97.2 39.6 0.41 2.05 13.1 
9.1 00 - 0 
0.16 18.9 118.2. 562.8 6.20 
0.70 00 - 0 
0.03 8.54 284.5 1355.5 2.8 
dl 2'-deoxyinosine, dC = 2'-deoxycytidine, Ade = adenine. 
(A) N-deoxyribosyltransferase-I; (B) - N-deoxyribosyltransferase-11. 
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SDS-PAGE 
The subunit composition of N-deoxyribosyltransferase-11 was 
confirmed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) using the Phastsystem method 
developed by Pharmacia. 
5ng (approximately) of sample VI(B) was heated for 5 minutes at 
IOOOC with 2.5% sodium dodecyl sulphate and 5.0% 0- 
mercaptoethanol. Bromophenol blue was added to approximately 
0.01% and any insoluble material removed by centrifugation. The 
sample was then loaded onto a Phast Gel, gradient 10-15 with 
Pharmacia SDS molecular weight marker proteins in the range 
53,000- 212,000. The gel was run using SDS agarose buffer strips 
and stained according to a modified high sensitivity silver 
staining method for SDS-PAGE Phast Gel media [114]. 
2.3.2 Physical Characteristics 
The relative molecular masses of N-deoxyribosyltransferase-I 
and N-deoxyribosyltransferase-II were determined on a TSK- 
Gel G4000SW column (7.8 x 300mm) which was equilibrated 
with lOmM phosphate buffer, pH 7.0, with a flow rate of 0.4 
ml min-1. The following calibration markers were applied to 
the column separately: blue dextran, (Mr2,000,000) 
thyroglobulin (bovine), (Mr 669,000) apoferritin (horse spleen, 
Mr443,000), P-amylase (sweet potato, K200, POOO), alcohol 
dehydrogenase (yeast, M050,000), albumin (bovine serum, Mr 
66,000). Elution volume was determined by peak absorbance at 
280nm. 
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The molecular masses of N-deoxyribosyltransferase-I and N- 
deoxyribosyltransferase-II are 100,000 +/- 4,000 and 92,000 
+/- 4,000 respectively (Figure 2.1). The values are an average 
of 3 runs. The subunit molecular weight of N- 
deoxyribosyltransferase-II was confirmed by SDS-PAGE (Figure 
2.2). 
The purine: purine activity of N-deoxyribosyltransferase-I was 
purified 207-fold and that of N-deoxyribosyltransferase-II, 
103-fold. The pyrimidine: purine activity was increased 1355- 
fold. N -deoxyribo syltran sf erase -II was purified to 
homogeneity (Figure 2.3). 
Isoelectric Focusigg 
The isoelectric point of the N-deoxyribosyltransferase-11 was 
determined by isoelectric focusing (IEF) using the Phastsystem 
method developed by Pharmacia. 5ng (approximately), was 
loaded onto a PhastGel IEF 3-9 with Pharmacia pl calibration 
markers comprising a mixture of proteins with p1s in the range 
3.50 - 9.30. 
The gel was silver stained according to the method set out by 
Pharmacia [1131. 
The pI of the N-deoxyribosyltransferase-II was calculated to 
be 5.2 (Figure 2.4). 
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Figure 2.1 Vo/V 
Determination of the Molecular Masses of 
N-Deoxyribosyltransferase-I and -11 
Conditions as described in the text 
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The thermal stability of the enzymes was compared by 
incubation at various temperatures between 350C and 850C 
prior to enzyme assay (Figure 2.4). These experiments 
demonstrate that distinct differences exist in the stability of 
the enzymes. At 600C, for example, N-deoxyribosyltransferase- 
I was inactivated after 20 minutes incubation, whereas N- 
deoxyribosyltransferase-II retained half its activity. 
CIS 
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Figure 2.2 Determination of Molecular Mass of 
N-Deoxyribosyltransferase-II by 
SDS-PAGE. Conditions as described in 
the text 
The influence of pH on the activity of the enzyme was seen by 
cn 
Gn 
performing the standard reaction conditions under a variety of 
pH conditions from pH 3.0 - 8.5 (Figure 2.5). The pH optimum 
of N-deoxyribosyltransferase-I is pH 6.0 and that of N- 
deoxyribosyltransferase-II is pH 5.6 (Table 2.3). Neither 
enzyme demonstrated activity below pH 3.0 or above pH 8.1. 
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Effect of pH on N-deoxyribosyltransferase-I and -11. 
Conditions as described in text. 
Table 2.3 
Temperature and pH Maxima and Optima 
N-deoxyribosyltransferase 
I Il 
Temp. optimum/OC 45 65 
Temp. Maximum/OC 65 85 
PH minimum 3.0 3.0 
PH optimum 6.0 5.6 
PH maximum 8.0 8.1 
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2.4 DISCUSSION 
leichmannii contains two forms of nucleoside 
deoxyribosyltransferase which are analogous in their physical 
and catalytic properties to those resolved from L. helveticus. 
Attempts have been made to purify nucleoside 
deoxyribosyltransferase from L. acidophilus [761, L. delbrueckii 
[77], and L. leichmannii [79,87], but few detailed studies have 
been published. 
Several reports describe the preparation of N- 
deoxyribosyltransf erase from L. leichmannii and inhibition 
studies have often been used to demonstrate that more than one 
deoxyribosyl transferase was present. Minghetti [78] noted that 
the reactions involving pyrimidines were inhibited when using 
Tris buffer. This was probably due to the inhibition of N- 
deoxyribosyltransferase-II by the Tris. The rates of 
purine: purine transfer were less inhibited, suggesting the 
presence of two or more enzymes. These phenomena have been 
observed in other species [76,80,81 ]. 
Beck and Levin [79] purified an N- deoxyribosyltransferase 
activity from L. leichmannii 151-fold by anion exchange, whilst 
Huang et al [871 attained a 260-fold purification using affinity 
chromatography. Both of these authors used thymidine as the 
donor nucleoside in the transfer reaction to assay all fractions 
during purification, and so failed to detect the purine specific 
enzyme. All the fractions obtained during this purification were 
assayed routinely for both purine: purine and purine: pyrimidine 
activity using 2'-deoxyinosine and 2-deoxycytidine respectively 
as donors by the HPLC method described above. 
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The present results indicate that two distinct enzyme species are 
readily separable by ion-exchange chromatography on high 
resolution HPLC columns (Figure 2.6). 
200 
Protein Absorbance, 
dl/A activity 
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NaCl gradient 
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Figure 2.6 
HPLC on DEAE 2SW ion exchange of a mixture of 
N-Deoxyribosyltransferase-I and -Il. 
Transferase activities were eluted with a linear 
0-0.5M NaCl gradient in lOmM phosphate buffer, pH6.0. 
30 
The Fast Protein Liquid Chromatography system facilitated the 
proficient handling of large amounts of material in a relatively 
short time span. Exploration ot aitterent types ot column 
compatible with this system could help to accelerate the whole 
scheme, improving the efficiency and the yield of the 
0.0 
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purifications. The hydroxyapatite-HPHT column step was 
introduced after the separation of the two activities in order to 
clean up the preparations. This was especially effective in the 
case of N-deoxyribosyltransferase-I which had little or no 
attraction for the column, even at very low salt concentration, 
and was eluted in the void volume (Figure 2.7[i]) The 
differential affinities of the two enzymes for the 
hydroxyapatite matrix suggests that this could be a possible 
method for the initial separation of the activities. Gel filtration 
was able to give reproducible values of the molecular masses 
for both enzymes. Although these proteins are of similar 
molecular masses, they can be distinguished by their thermal 
properties (Table 2.3) and reactivity towards pyrimidines. 
Analogous enzymes have been purified from L. helveticus [81, 
110] and designated nucleoside deoxyribosyltransferase-I, 
which catalyses the transfer of purine bases and nucleoside 
deoxyribosyltransferase-II, which catalyses the transfer 
between purine and pyrimidine bases. We have adopted this 
nomenclature. 
N-Deoxyribosyltransferase-II was purified to homogeneity as 
demonstrated by a single band on a native polyacrylamide gel. 
Its molecular mass was determined by gel permeation 
chromatography and confirmed by SDS-polyacrylamide gel 
electroph ores is. The SDS gel also defined the subunit composition 
of the enzyme and the appearance of a single band on this gel 
implies that the enzyme is a single polypeptide. Holguin's 
preliminary results indicated that purine specific enzyme from L. 
helevticus was a polymeric enzyme. 
57 
Protein absorbance 
Activity dl/Ade 
Gradient 
60 
1.0 
E 
40 
20 
r_ 
C: ) 
00 
u 
r_ 
cz 
0.1 
0.. 16 &1 . 0ý I 
0 20 
Figure 2.7[i] 
30 
20 
10 
40 60 
Fractions 
RPLC on Hydroxyapatite-HPHT of 
N-deoxyribosyltransferase-I 
0.5 
E 
r_ 
C: ) 
00 
-0 t- 
o 
0I 
0 
Figure 2.7[ii] 
-1 0.1 
80 
HIPLC on Hydroxyapatite-HPHT of 
N-deoxyribosyltransferase-II 
The N-deoxyrobosyltransferase activities were 
eluted from their respective columns with a 
linear 0.01-0.4M gradient phosphate buffer, 
O. ImM calcium chloride, 0.05% sodium azide, pH 6.8 
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Cook et al have reported the molecular weight of a recombinant 
L. leichmannii nucleoside deoxyribosyltransferase enzyme to be 
110,000 and have shown it to have a hexameric subunit 
composition [115]. It is unclear as to whether this enzyme is 
analogous to either of the N-deoxyribosyltransferase enzymes 
that we have purified here. 
It is not expected that this protein is glycosylated since the 
proteins of prokaryotic organisms do not undergo this type of 
post-translational modification. 
The N-deoxyribosyltransferase-II enzymes in both L. leichmannii 
(Figure 2.8) and L. helveticus [81,1051, are more stable to heating 
than the corresponding N-deoxyribosyltransferase-I enzymes. 
An extremely stable enzyme is reported to be present in L. 
leichmannii ATCC 4797 [85] and is probably identical to N- 
deoxyribosyltransferase-II. It is suggested that two enzymes 
exist in L. lactis and L. delbrueckii. This prediction is based on 
the finding that L leichmannii and L. lactis together with L. 
bulgaricus are subspecies of L. delbrueckii, and not separate 
species [75]. 
The thermal stability of the N-deoxyribosyltransferase-II could 
be exploited both in a purification procedure and in its role as a 
biocatalyst [851. Beck and Levin used a heat denaturation as the 
initial step in their purification of N-deoxyribosyltransferase 
activities from L. leichmannii [79]. By this method it is likely that 
they destroyed quite a large fraction of the heat-labile purine- 
specific enzyme, decreasing the chances of its detection under 
suitable assay conditions. Its value as a purification step in this 
instance would arise after the separation of the two enzymes. 
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The pH curves for N -deox yri bosy Itran s ferase -I and N- 
deoxyribosyltransferase-II are very similar, suggesting that the 
same type of amino acid groups might participate in binding and 
catalysis at the active site. 
120 
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Figure 2.8 Thermal inactivation profiles of 
N-Deoxyribosyltransferase-I and II. 
Conditions as described in the text 
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The Michaelis constants we determined of 4ýtM and 10ýLM in the 
transfer reaction from 2'-deoxyinosine to adenine for N- 
deo, xyribosyltransferase-I and 41 respectively, were surprisingly 
low. By contrast, a value of 41ýtM was obtained for N- 
deoxyribosyltransferase-I from L. helveticus [83]. However, 
direct comparison is difficult since the Km values for 2- 
deoxyinosine vary with the concentration of adenine [79,110] 
and some deoxyribonucleo sides [791. The apparent Kms of these 
reactions were determined using a xanthine oxidase coupled 
enzyme assay system. This procedure, however, has some 
practical disadvantages compared with the standard HPLC 
method. Care must be taken to ensure that the xanthine oxidase 
does not limit the rate of conversion of hypoxanthine to uric acid 
and, since adenine is a substrate of the xanthine oxidase, the 
conditions must be controlled so as to minimize this side reaction 
and corrections made for the conversion of adenine to 2', 8- 
di hydroxy adenine. Detailed studies are required to elucidate 
these effects. 
The majority of the assay systems for measuring N- 
deoxyribosyltransferase activities have concentrated on 
spectrophotometric methods [82] using coupled enzyme systems 
or colour reactions [77,79] which measure the concentration of 
free 2'-deoxyribose in solution. Although convenient for 
reconnaissance experiments, the diphenylamine colour reaction 
[109] was not able to be usefully employed throughout the 
purification procedure. The reaction relies upon the acid stability 
of the pyrimidine nucleosides compared to the acid lability of the 
purine nucleoside which, when treated with diphenylamine 
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reagent, liberates the 2-deoxyribose group. Thus, it is unable to 
monitor the purine: purine transfer reaction. The blue colour 
which is generated by the reaction of the reagent with the 21- 
deoxyribose, is conveniently measured spectrophotometrically. 
The high performance liquid chromatography method was 
developed with C8 and C18 reverse phase columns. The bases and 
nucleosides were generally eluted isocratically using a mobile 
phase of water and methanol but for some compounds it was 
necessary to develop a gradient program using a combination of 
different solvents. 
Although this purification scheme was successful in separating 
two distinct nucleoside deoxyribosyltransferase activities from L. 
leichmannii, there are several ways in which the initial 
purification steps could be modified to secure an improved yield. 
The microaerophilic growth of L. leichmannii, proved to be easy, 
and relatively large amounts of biomass were obtained with 
small to medium scale growth. However, the 
deoxyribosyltransferase enzymes constitute less than 1% of the 
total intracellular protein. One way of boosting the levels of 
enzyme activity would be to take advantage of the vitamin B12 
salvage pathway and grow the L. leichmannii, under vitamin B12- 
or de oxyribon ucleoside- starvation conditions [92,951. The ratios 
of activities towards reactions (a), (b) and (c) varies from strain to 
strain however, and it is unclear which of these activities would 
be increased [751. 
Methods used to break the cells including sonication and the 
french pressure cell lack the ability to cope with large volumes of 
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material, and samples have to be treated batchwise, and quite 
often the process has to be repeated. Disruption of the cell walls 
using the combination of lysozyme and mutanolysin proved to be 
very effective and reduced the required number of passages of 
the cells through the french pressure apparatus. A combination 
of sonication and french press methods have been tried in 
subsequent preparations of crude extracts from L. leichmannii. 
This has resulted in extracts with specific activities of 0.155units 
mg-I and 0.866units mg- 1 for the purine: purine and 
pyrimidine: purine activities respectively for the new method, 
compared with 0.086units mg-I and 0.21units mg-I for the 
purine: purine and pyrimidine: purine activities respectively for 
the initial method of disruption. 
Speculations on the existence of a pyrimidine- specific enzyme 
have been made and Cardinaud and Holguin have managed to 
separate a discrete pyrimidine: pyrimidine activity from an 
extract of L. helveticus using an affinity column [116]. A 
distinctive third band of activity was observed to be present in 
one purification of the N-deoxyribosyltransferase enzymes from 
L. leichmannii, eluting from the FPLC MONO-Q high resolution 
anion exchange column immediately af ter the N- 
deoxyribosyltransferase-Il enzyme. This activity was not seen in 
subsequent preparations. 
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CHAPTER 3 
SUBSTRATE SPECIFICITY 
GENERAL BACKGROUND 
The marked specificity towards particular types of ligands is one 
of the characteristic properties of some proteins which enables 
them to distinguish between closely related molecules. This 
ability allows antibodies to differentiate between self and non- 
self, while an enzyme is able to select only those ligands which 
fulfil the structural criteria defined by the active site. 
The nature of the forces involved in the binding and specificity of 
these ligands are well understood. 
governed by hydrophobic interactions, 
hydrogen bonding plays a vital 
Binding is thought to be 
In the same way that 
part in maintaining the 
conformation and structure of proteins and nucleic acids, the 
specificity of an individual enzyme for its substrate is provided 
by inter alia hydrogen bonding interactions and salt bridge 
formation [1171. Attempts have been made to quantify the 
relative contribution that each of these forces makes [1181. 
One way to chart the active site of an enzyme is to establish the 
three dimensional layout of the binding pocket. This can be 
achieved by examination of the specificity of the individual 
enzyme. A series of analogues can be constructed by making 
systematic modifications to a natural substrate. These are tested 
to see if they are suitable substrates, giving information on the 
ligand positions essential to binding and specificity. With these 
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data a model can be constructed to illustrate how these ligands 
might interact with specific amino acids in the active site. Even 
when an analogue fails to act as a substrate, it can still yield 
valuable information. In these cases it has to be established 
whether the non-substrate actually binds to the protein at the 
active site and inhibits the approach or binding of the natural 
substrate; whether it fails to contact the binding pocket due to 
steric constraints on the part of the protein or the ligand, or, 
having reached the active site, is unable to secure a stable 
binding position. 
In the N-deoxyribosyltransferase reaction, substrate specificity 
studies must explore the enzymes' selectivity for both sugar and 
heterocyclic base. Substrate-activity studies with nucleoside 
phosphorylases from mammalian and bacterial sources have 
aided the construction of models of active site geometries in 
several of these enzymes [102]. In certain cases, it has enabled 
predictions to be made regarding the involvement of selected 
amino acids in the binding and specificity of substrates. 
Substrate specificity for N-deoxyribosyltransferase enzymes has 
be examined in a number of species, but as yet only detailed 
studies have been carried out on the N-deoxyribosyltransferase- 
11 enzyme from L. helveticus [103]. 
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EXPERIMENTAL METHODS 
Compounds were commercially available except where indicated 
in the tables. 
Deoxyribosyl transLer to Base Analogues: 
Deoxyribosyltransfer from 2'-deoxyinosine (N- 
deoxyribosy I tran sf erase -1), and 2'-deoxycytidine (N- 
deoxyribosyltransferase-11) to various base analogues was 
measured by the monitoring the production of new 21- 
deoxynucleoside with HPLC. The reaction mixture contained the 
same concentrations as the standard mixture with the 
exception of the donor concentration which was raised to 
0.3gmol, to give a final donor: acceptor ratio of 3: 1. The reaction 
was initiated by the addition of approximately lOmU enzyme. 
After 3h the mixture was eluted with a 15 minute linear 
gradient of methanol 7-35% on a Technopak HPLC column (7-8 
x 100mm) and the production of the new 2'-deoxynucleoside 
recorded. Products were identified by their elution times using 
authentic nucleosides as standards. Certain reactions were 
followed by base release from the substrate nucleoside or by 
the disappearance of the acceptor substrate. This allowed 
reactions to be followed where either the acceptor base 
demonstrated a weak absorbance at 254nm or where the 
nucleoside product product had a strong affinity for the CI 8 
material and elution from the HPLC column was as a broad, 
diffuse band of product. Novel nucleoside products were 
identified by ultraviolet and nmr spectroscopy. 
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Deoxyribosyl transfer from Sugar Analogues: 
In the case of deoxyribosyl transfer from nucleosides with 
modified pentosyl groups to natural base acceptors, the 
reaction mixture contained 25gmol Pipes, pH 6.5, O. Igmol 
donor and 0.05ýtmol acceptor in a total volume of 0.5ml. 
Hydrolysis ot ribose group from 7-Deazaadenosine.. 
7-Deazaadenosine (50mg) was refluxed in 100ml of 10M HCI for 
48h. The hydrolysis reaction was followed by monitoring the 
release of the base by HPLC. The base and nucleoside were 
readily separated on the gradient system described above. 
Identification of Nucleoside Products of 8-Bromoadenine and 
Xanthine. (N-deoxyribosyltransferase-LIJ 
Two products were isolated from each of the separate reactions 
between the donor nucleoside 2'-deoxycytidine and the purine 
bases xanthine and 8-bromoadenine. The initial transfer 
reactions were carried out as described above. Fractions were 
collected of two discrete product peaks from each reaction as they 
eluted from the HPLC column. Those fractions from the 2, - 
deoxycytidine/xanthine transfer were designated XI and X2 and 
those from the 2'-deoxycytidine/8-bromoadenine reaction Al and 
A 2. These fractions were examined spectrophotometrically 
(Tables 3.9 & 3.10) and tested as competent donors of the 
glycosyl group. For the reverse transfer each reaction mixture 
contained 0.2ýLmol acceptor base, 50gmol of Pipes buffer, pH 6.5, 
in a volume of 0.5ml of the eluant sample. The base for XI and X2 
was adenine and that for Al and A2 cytosine. The reaction was 
initiated by the addition of approximately 4mU of enzyme. 
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The N-deoxyribo sy I tran sf erase reaction was assayed by 
measuring the formation of the new nucleoside at 400C using 
IHPLC. 
DlCStjLrM 
r%. JLL 
All purine compounds were examined for their ability to act as 
substrates in the transfer reaction with both N- 
deoxyribosyltransf erase -I and -11 enzymes. Pyrimidine 
compounds were tested as potential acceptors with N- 
deoxyribosyltransferase-II, and nucleosides with modified sugar 
groups were tested with both enzymes. 
Purine Analogues 
Eff-ect ot Modilication on Positions I and 3 
This experiment demonstrated that with one exception, the 
removal or replacement of the N-I or N-3 with a carbon, did not 
affect the ability of the purine base to act as an acceptor (Table 
3.1). Thus, compounds such as I-deazapurine, benzimidazole, and 
benzotriazole were substrates. In contrast, the 3-deazaadenine 
was found not to be an acceptor. It was also observed that when 
the pyrimidine ring structure is incomplete as in the case of ethyl 
4-aminoimidazole-5-carboxylate and its 4-hydroxy counterpart, 
the base was still able to participate in the transfer reaction 
(Table 3.2). Complete removal of the pyrimidine ring resulted in 
a much reduced activity as seen with 1,2,4-triazole. Imidazole is 
not a substrate. 
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Effect of Modilication on Position 6 
A number of varied 6-substituted purine analogues were 
examined as substrates (Table 3.3,3-4) Without exception these 
were found to act as competent acceptors for the glycosyl group 
in both the purine: purine and pyrimidine: purine reactions. Even 
compounds with bulky substituents such as 6- 
furfurylaminopurine and N6-ethenoadenine, and those with 
hydrophobic side chains were observed to be good substrates. It 
was observed that on increasing the size of the subtituent on the 
dialkylsubstituted purines, that the reaction velocity decreased. 
The 2,6 -di substituted purines, xanthine and 2,6-diaminopurine 
were also good acceptors but their respective velocities compared 
to the natural mono- substituted purines hypoxanthine and 
adenine, were considerably lower. The transfer reaction of 
xanthine with both purine and pyrimidine donors generated two 
products X1 and X2. 
Effect of Modification on Position 7 
Purine bases substituted in the 7-position were not acceptors in 
the reactions catalysed by either N-deoxyribosyltransferase-I or - 
11 (Table 3.5). The compounds 7-deazaadenine and indole, where 
the N-7 was replaced by a carbon, were also non-substrates. The 
7-deaza-8-aza compounds 4-aminopyrazolo[3,4-d]pyrimidine and 
its 4-hydroxy counterpart however, were substrates for both 
enzymes. 
Effect o, Modification on Position 8 
All but one of the 8-modified analogues tested were substrates 
(Table 3.6). While 8-aza compounds were very competent 
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acceptors, the 8-substituted analogue 8-bromoadenine had a 
much a decreased reaction velocity compared to the parent 
adenine. 8-bromoadenine, like xanthine, also gave rise to two 
discrete products, Al and A2. A decreased velocity for 8- 
bromoadenine, and the observation that uric acid was not a 
substrate, indicates that 8-substituted analogues are unable to 
reach the active site readily because of steric hinderance. 
Pyrimidines Analogues 
Effect ot Modincation on Position I 
Substitution at the N-1, the primary site of glycosylation, was not 
tolerated as observed by the non-reaction of I-methylthymine. 
Effect of Modification on Position 5 
A number of modifications were tolerated at the 5-position of 
uracil, from a number of small halogen groups to large, 
hydrophobic alkyl substituents (Table 3.7,3.8). Alkyl 
substitution was however, tolerated only to a small degree 
indicating that there might be a binding pocket of defined size at, 
or near this position. 
Replacing the carbon at the 5-position was found to abolish the 
acceptor activity. 5-azacytosine was found to be a weak inhibitor 
of the pyrimidine: purine transfer reaction. 
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Effect ot ModiCication on Positions 2 and 6 
Three disubstituted cytosine analogues examined were found to 
be non-substrates, indicating that these positions are conserved 
for binding and catalysis. A series of 5-alkyl-2-thioluracils were 
also tested and found not to act as acceptors (Table 3.7). 
In tables 3.1-3.7, % 3h-I and %3h-11 denote the percentage of 
new N-deoxyribosyl nucleoside product formed in three hours in 
the transfer reactions employing purified N-deoxyribosyl- 
transferase-I and -11 respectively. 
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Table 3.1 
Effect of Modification on Positions I and 3 
I Compound 11 Structure 11 %3h-I I %3h-II I 
Purine 
1-Deazapurine 
N 
N 
L 
N 
H 
CN 
H 
86.6 87.3 
Benzimidazole 
H 
OPI 
Indole 
NHq 
3-Deazaadenine 
90.7 86.8 
25.1 27.2 
00 
00 
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ON 
N 
3 
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Table 3.2 
Effect of Modification on the Purine ring 
Compound 11 Structure 11 %3h -1 
1 %3h-II 
0 
H2N N 
4-aminoimidazole 
-5-carboxamide H2N 
CN 
H 
0 
CH3CH20 N 
Ethyl-4- 
aminoimidazole N 
-5-carboxylate H2N H 
0 
CH3CH20 N 
Ethyl-4- 
hydroxyimidazole HO N 
-5-carboxylate *H 
1,2,4-Triazole N LN 
H 
N 
Imidazole 
cl 
N 
H 
Gift of Dr. G. MacKenzie, 
Humberside College Further Education, Hull. 
86.8 68.3 
24.7 64.5 
20.2 38.6 
17.9 22.4 
00 
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Table 3.3 
Effect of Modification on Position 6 
Compound 11 Structure 11 %3h-I I %3h-II 
6-Chloropurine 
Hypoxanthine 
N6-ethenoadenine 
cl 
N) 
Sss N 
tzzý. 
#I- 
ir ý 
NN 
H 
0 
HN N CN 
N 
H 
JCN 
N 
H 
FOXH2-NH 
6-furfurylaminopurine N) 
N 
H 
2,6-Diaminopurine 
Xanthine 
NH2 
NN 
HN).: 
ý* NN 
2H 
0 
. 0001 N HN 
N 04J NH 
H 
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89.9 90.3 
85.8 
32.1 38.9 
37.5 24.7 
48.2 41.8 
55.5 41.3 
r, o, 1 
Table 3.4 
Effect of Modification on Position 6 
Compound I Structure I %3h-I I %3h-ll_ 
NH2 
N 
Adenine 
NN 
H 
NHMe 
Methyladenine N \> 
NN 
H 
H3C H3 
N 
Dimethyladenine > 
NIN 
H 
HWH2C. 
%N' 
CH2CH3 
Diethyladenine* N 
Ný 
ýzs. 
NN 
H 
H3C2(H2C) **N / 
(CH2)2CH3 
N 'I" 
N 
Dipropyladenine I \> 
NN 
H 
H3C3(H2C) (CH2)3CH3 
N 
Dibutyladenine* NN 
NN 
H 
97.5 
99.0 
98.1 
62.1 
52.3 
44.9 
*Gift of Ms. S. Brennan, University of Warwick. 
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98.1 
85.7 
77.9 
48.8 
38.9 
36.1 
1(8 
Table 3.5 
Effect of Modification on Position 7 
Compound T- Structure %3h-I %3h-II 
0 
CH3 
1 
HN 
N 
7-Methylguanine /> 
,0 se. N H2N N 
7-deazaadenine 
NH2 
N 
LýN 
MN 
H 
0 
HN- 
4-hyroxypyrazolo- 
[3,4-d]-pyrimidine 
N 001, 
NH2 
4-aminopyrazolo- 
[3,4-dl-pyrimidine 
[ZýeN 
oto, 
N 
/ 
N 
H 
N 
/ 
N 
H 
00 
00 
42.6 11.2 
80.2 86.6 
67 
'00 
N 
3 
76 
Table 3.6 
Effect of Modification on Position 8 
Compound 11 Structure 11 %3h-I I %3h-Il 
8-Bromoadenine 
8-Azaadenine 
* 4-aminopyrazolo- 
[3,4-dl-pyrimidine 
*4-hyroxypyrazolo- 
[3,4-d]-pyrimidine 
Benzotriazole 
Uric Acid 
NH2 
-. 
1 
Ný N ý-Br 
N 
:N 
H 
NH2 
N 
N 'ýo I\ 
N 
CN 
H 
NH2 
N 
LN 
NN 
H 
0 
HN 
) 
J# 
N 
NN 
H 
tN 
HN N ý=o 
0, 
woo 
4-. 
:N 
NH 
H 
28.2 
69.2 
80.2 
42.6 
20.2 
0 
*included in Tables 3.5 and 3.6 as they are 
modified at both the 7- and the 8-positions 
35.6 
21.1 
86.6 
11.2 
17.5 
0 
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Table 3.7 
Effect of Modification on Positions 2,4,5 and 6 
on the Pyrimidine ring 
2 4 5 6 
*S -OH H H 
*S -OH CH3 H 
*S -OH CH2CH3 H 
*S -OH (CH2)2CH3 H 
*S -OH CH2(CH3)2 H 
*S -OH (CH2)3CH3 H 
-NH2 -NH2 H -OH 
+-OH 
-NH2 H -OH 
+-ci -NH2 H -ci 
+-OCH3 
-NH2 H -OCH3 
*Gift of Ms. N. Hicks, University of Warwick. 
+Gift of Dr. J. P. Madley, Courtaulds Research p1c., Coventry. 
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Table 3.8 
Effect of Modification on Position 5 of Uracil 
Compound 2/4 5 +/- 
Uracil -OH H + 
5-Methyluracil -OH CH3 + 
*5-Ethyluracil -OH 
CH2CH3 + 
*5-Propyluracil -OH (CH2)2CH3 
*5-i-Propyluracil -OH CH2(CH3)2 » 
*5-Butyluracil -OH (CH2)3CH3 » 
5-Fluorouracil -OH F + 
5-Chlorouracil -OH ci + 
5-Bromouracil -OH Br + 
5-lodouracil -OH I + 
5 -Trif lu oromethyluracil -OH CF3 
+ 
5-Aminouracil -OH NH2 
+ 
5-Nitrouracil -OH 
N02 + 
5-Carboxyuracil -OH COM m 
(E)-5-(2-bromovinyl)uracil -OH CHBr 
*Gift of Ms. N. Hicks, University of Warwick. 
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DISCUSSION 
Several conclusions with regard to the structure-activity 
relationship between the heterocyclic rings and the sugar group 
of the donor nucleoside with the N-deoxyribosyltransferase 
enzymes can be made from these results. Diverse purine 
analogues have been shown to be substrates of N- 
deoxyribosyltransferase-11 from L. leichmannii and L. helveticus, 
but the substrate range of N-deoxyribosyltransferase-I has not 
been described. 
PURINE ANALOGUES 
Tables 3.1-3.6 show that N-deoxyribosyltransferase-I utilised the 
same range of purine analogues as N-deoxyribosyltransferase-11. 
It can be concluded that the positions 1,2,3 and 6 are not 
essential for binding. Indeed when the pyrimidine structure is 
removed, the analogue, although at a much reduced reaction rate, 
still acts as a substrate. The ability of the enzyme to accept such 
a variety of 6-substituted purine analogues suggests that these 
probably reside in a large binding pocket. The fact that the 
reactions employing analogues with larger side chains proceed at 
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a relatively slow velocity could be due to some steric hinderance 
on the part of the substituent or to tighter binding of the 
substrate if the region is hydrophobic in character. The reasons 
why the 3-deazaadenine is not a substrate are unclear as it has 
been shown quite catagorically that this position is unnecessary 
to allow the molecule to participate in the transfer. Holguin and 
Cardinaud [881 have shown that substitution at this position with 
a methyl group gives a very slow acceptor. Replacement of the 
N-3 with a carbon could put the molecule under some 
conformational strain which prevents it from either entering the 
active site easily or being able to bind. The discovery that two 
imidazole-5-carboxylates and one imidazole carboxamide [119], 
which lack the six membered ring, were also competent acceptors 
confirms that the action of this part of the base in binding is of 
secondary significance. Therefore, the important part of the 
structure, and one which is common to all proficient acceptors, is 
the imidazole ring. 
From the non-reactivity of the 7-modified purine analogues it is 
possible to conclude that either the nitrogen at N-7 is critical for 
binding, or that a tautomeric proton is required in the imidazole 
ring. Although there are four possible tautomers of purine, in 
solution the purine will exist as the 7-H and the 9-H tautomers. 
Since the site of glycosyl substitution must possess a proton, this 
suggests that the 9-H tautomer is the dominant one. 
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9-H tautomer 
Figure 3.1 
H 
7-H tautomer 
When the nitrogen is replaced by a carbon in the case of 7- 
deazaadenine, or modified, 7 -methyl guanine, this tautomeric shift 
is unable to take place. The observation that 4- 
aminopyrazolo[3,4-d]pyrimidine and its corresponding 4-hydroxy 
analogue were a competent acceptors suggests that this 
tautomeric shift can occur between the 8 and the 9 positions in 
the absence of the 7-position nitrogen. This last observation 
supports the theory for N-7 as necessary for tautomeric shift 
rather than essential binding. Although the 4- 
hydroxypyrazolo[3,4-d]pyrimidine was a very poor substrate for 
N-deoxyribosyltransferase-11, its reaction with the purine: purine 
enzyme was much better. These results are contrary to those 
obtained by Holguin who found this compound was not accepted 
by the N-deoxyribosyltransferase-11 from L. helveticus [88]. The 
8-azaadenine proved to be a reasonable acceptor which is in 
agreement with examination of these compounds with the N- 
deoxyribosyltransferase of other species [76,77,80,1201. 
8-Substituted compounds, were observed to be very slow 
acceptors or non-substrates. In the glycosyl transfer to 
8- 
bromoadenine, the slow reaction generated two products. The 
reduction in the reaction velocity could be due to the 
bromine 
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substituent sterically hindering the approach of the purine 
molecule into the active site. In this instance it is thought that 
the molecule seeks an alternative access to normal binding and 
docks into the protein catalytic site via the pyrimidine rather 
than the imidazole ring. This solution means that a tautomeric 
shift can now exist between the 9- and the 3-positions, allowing 
the production of the 3-p-D-deoxyribonucleoside. Isolation of the 
two products eluting from the HPLC column enabled a brief 
characterization. A UV spectrum of one fraction demonstrated a 
large shift of kmax in accordance with the presence of the 3-P-D- 
deoxyribonucleoside (Table 3.9). This is in agreement with the 
results of Huang et al. [87] who examined a number of 8-halo- 
substituted adenine analogues and found two products: the 3- 
and the 9-P -D -deoxyri bonucl eo side. 
Compound 
Table 3.9 
pH 11.0 
kmax X280/260 
8-bromoadenine 271.8 0.98 
Al 294.8 1.38 
A2 266.9 0.56 
Huang also observed that a trend existed between the ratios of 
the two products and the electronegativity of the group at the 8- 
position: the greater the electronegativity of the substituent, the 
greater the proportion of the 3-0-D-deoxyribonucleoside formed. 
In all cases these reactions were found to proceed at much slower 
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rates compared to the parent adenine. 
The fractions separated from this reaction mixture were also 
tested independently for their ability to act as glycosyl donors in 
the transfer reaction. Both were able to function competently 
donating the deoxyribose group to a cytosine acceptor. When uric 
acid was used as an acceptor there were no products. This is 
most likely due to obstruction by the 8-hydroxy group making 
the active site inaccessible. 
In view of the initial results that the pyrimidine ring did not 
seem to play a large part in governing either the ability for an 
analogue to act as an acceptor or influencing the site of glycosyl 
substitution, the observation that xanthine gave two products was 
unexpected. Holguin and Cardinaud [1211 reported that in their 
reaction of thymidine with xanthine using the N- 
deoxyribosyltransferase-11 enzyme from L. helveticus, the major 
product was the 7-p-D-deoxyribonucleoside, as identified by UV 
spectroscopy. The two products collected from the reaction 
between 2'-deoxycytidine and xanthine were also found to have 
distinct spectral properties. Examination of the XI product 
demonstrated a marked spectral shift from the xanthine free base 
and the 9-0-D-deoxyribonucleoside (Table 3.10 ). 
Table 3.10 
pH 11.0 
Compound kmax A, 250/260 
Xanthine 277.4 1.44 
X1 291.7 0.86 
X2 274.2 - 
X280/260 
1.87 
3.03 
0.946 
X290/260 
3.5 
0.57 
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This is similar in magnitude to the UV shift shown by the Al 
product isolated from the 8-bromoadenine reaction and it is 
suspected that this X1 product might also be the 3-P-D- 
deoxyribonucleoside. Mammalian pyrimidine phosphorylases, 
despite their strict structural ligand requirements, are able to 
accept xanthine as a substrate, and give the 3-P -D- 
deoxyribonucleoside product [122,123]. This would suggest that 
the enzyme is viewing the purine as a pyrimidine, recognising the 
six-membered ring as a uracil analogue and placing the glycosyl 
group onto the N-1 pyrimidine position of the ring. It could be 
considered that the N-deoxyribosyltransferase-II enzyme from L. 
leichmannii is identifying the xanthine in the same way, allowing 
the substrate to interact and bind via the 2-and 6-hydroxyl 
groups to the active site with the concurrent formation of the 3- 
P -D-xanthine deoxyribonucleoside. Since the enzyme is 
recognised to have the ability to express some flexibility toward 
tautomerism, as witnessed by its acceptance of 7-deaza-8-aza 
compounds, it is thought that the synthesis of this compound is 
more likely to occur than the production of the 7-0-D- 
deoxyribonucleoside proposed by Holguin and Cardinaud. This 
conclusion could be extended to include a compound such as 
guanine which, like xanthine, possess a 2-hydroxy substituent. It 
is possible that this base could also bind in a similar fashion, 
reacting to give two distinct products. Very little detailed work 
however, has been performed on guanine and its base analogues 
because of problems of solubility in aqueous media. Further 
studies are required to clarify these phenomena. The 2,6- 
diaminopurine base has been shown to be a non-substrate for the 
N-deoxyribosyltransferase enzymes from L. helveticus [71], and 
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L. acidophilus [76]. However, in agreement with the conclusions 
drawn so far, the base is an acceptor for both enzymes from L. 
leichmannii. These data have enabled a model to be constructed 
for the binding of a purine base or nucleoside with the N- 
deoxyribosyltransferase enzymes from L. leichmannii (Figure 
3.2). 
NH2 
Figure 3.2 
PYRIMIDINE ANALOGUES 
4 
3 HN 
6 02N 
H 
Substitutions on the pyrimidine structure of such a wide variety, 
are not so easily accepted by the N-deoxyribosyltransferase-Il 
enzyme as those made on the six membered ring of the purine. 
Modification to the N-I position meant loss of acceptor capability; 
similarly substitutions at the C-2 position did not permit transfer. 
From the observations it can be concluded that tautomerism 
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between the I- and the 2- positions is necessary for activity 
(Figure 3.3). 
0 
HN HN 
HO N 
1 
H 
Figure 3.3 
Removal of the hydroxyl at the 2-position altogether, as in 
pyrimidine or pyrazines* gave analogues which were non- 
substrates. Disubstituted compounds at the 2- and the 6- 
positions were also inactive, indicating that all of these sites seem 
to be crucial in competent acceptors (Table 3.7). Modifications at 
the 5-position seemed to suggest that this might be analagous to 
the 6-position on purines with respect to its versatility. Various 
changes were made at this position and, with few exceptions, all 
the analogues were substrates (Table 3.8). Smaller substituents 
like the halogens were observed to react readily, but some larger 
alkyl groups, were unable to do so. It appeared that once the size 
of the alkyl substituent had reached a certain size, any further 
increase resulted in an inactive compound. This seems to suggest 
the presence of a binding pocket of defined size and shape close 
to this position which is reluctant to accommodate very bulky 
groups. 
*Gift of Mr. A. O'L. Richards, University of Warwick. 
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The introduction of the carboxyl group probably changes the 
pyrimidine ring structure debilitating efficient binding and 
renders the base unacceptable as a substrate. The (E)-5-(2- 
bromovinyl) group is probably sterically constrained and unable 
to fit into the binding pocket. More information on the exact 
dimensions and nature of this pocket could be gained from 
comparison of binding constants with the electronegative and 
hydrophobic characteristics of 5-substituted analogues. From 
these results it might be envisaged that the pyrimidine ring binds 
in the active site as depicted a follows (Figure 3.4), anchoring 
itself by hydrogen bond interactions between the substituents at 
positions 2-, 4- and 5. 
I. 
. D%Ejl 
0. 
Figure 3.4 
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MODIFIED SUGAR GROUPS 
5' 0 Base 
It 
3 2' 1 
R' R 
In contrast to the wide range of bases that act as competent 
acceptors with N-deoxyribosyltransferase-I and -II, few 
modifications on the sugar moeity are tolerated. The results 
demonstrate that analogues that lack a hydroxyl group in the 3- 
or 51- positions are able to be transferred to purines and 
pyrimidines. With the Y-position, only a hydrogen can the 
replace the hydroxyl group to retain transfer capability, but at 
the 5'- site a number of substitutions are tolerated by the 
enzymes (Figure 3.5). Similar reactions have been demonstrated 
with 2', 5'-dideoxy-5'-fluorothymidine [110], and 21,3'- 
dideoxyribonucleo sides [ 100], with nucleoside N- 
deoxyribosyltransferases from L. helveticus. Substitutions of 
hydrogen atoms on the pentose ring with hydroxyl groups 
abolishes activity. Two carbocyclic deoxyribonucleo side 
analogues of unknown structure were provided by Glaxo Group 
Research, but neither was active as a substrate. Likewise, no 
arabinose sugar tested was accepted by the enzymes. 
Observations that a number of 3 '-substituted-2'-deoxyribose 
sugars were not capable of participating in the transfer, led to the 
examination of Y-fluoro substituted sugars (1). 
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Figure 3.5 
STERIC REOUIREMENTS OF SUGARS 
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(1) 
Because the fluorine group is of very similar size to the hydroxyl 
group it replaces, the aim was that such a substitution would 
provide information on the role of the T-hydroxyl in hydrogen 
bond interactions. The fluorine cannot act as a hydrogen bond 
donor, although it can be weak acceptor. Although none of the 
fluoro-substituted sugars were able to be transferred, some 
degree of hydrolysis was observed indicating that the compound 
actually binds to the enzyme. This could be because the sugar is 
binding weakly or in the wrong conformational state for catalysis. 
It is recognised that, depending on the substituents, the pentose 
ring can adopt different conformations. This preference may 
account for the unstable binding of the fluoro -substituted sugars. 
Thus, the Y-hydroxyl plays a central role in deoxynucleoside 
recognition and binding of the sugar moiety for efficient transfer 
activity. 
Base 
R R 
Figure 3.6 
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The structural features necessary for activity with these enzymes 
have been defined by this study. Not only is this information 
important in assessment of the enzyme recognition and binding, 
but also when N-deoxyribosyltransf erases are used as 
biocatalysts in the preparation of nucleoside analogues. Although 
both forms of N-deoxyribosyltransferase from L. leichmannii are 
suitable in these biotransformations, N-deoxyribosyltransferase- 
II is preferred as a result of its greater thermal stability (Figure 
2.7). 
Crude extracts have been used to synthesize milligrams quantities 
of the deoxyribosides 1-deazapurine [32] and 4-amino-imidazole- 
5-carboxamide, [1191 and the 2', 3'-dideoxynucleo sides of N-(6- 
hexyl-)substituted purines [124]. Since there appears to be some 
correlation between the conformational states of the sugar rings 
and the antiviral activity of the resultant nucleoside [125], 
knowledge of the preference exhibited by the N- 
deoxyribosyltransferase enzymes for these different conformers 
would also be useful in the design of therapeutically active 
nucleoside analogues. 
Consideration of this aspect of the active site also allows the 
structural features required by an inhibitor to be identified. This 
enables the design of inhibitors for studies such as chemical 
modification, and the construction of affinity adsorption columns 
for enzyme purification. 
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CHAPTER 4 
ACTIVE SITE MODIFICATION 
j. 1 GENERAL BACKGROUND 
The principal step in an enzymatic reaction is the recognition and 
binding of a specific ligand or substrate. As detailed in the 
Introduction, the resulting interaction occurs at a defined binding 
site at or near the surface of the enzyme which is shaped by a 
number of amino acid side residues whose side chains contact the 
substrate. The residues in or around this active site can either 
participate in the bond-breaking and bond-making events that 
proceed during chemical catalysis or contribute to the flexibility 
and stability of the binding pocket. Auxilliary amino acids are 
involved in securing the precise orientation of the substrate for 
catalysis. Other residues outside the active site provide a 
foundation for the binding groups maintaining the necessary 
three-dimensional protein structure in solution to facilitate 
efficient catalysis [1]. These amino acids play no dynamic role in 
the enzyme's action. 
The detailed characterization of the active site has remained of 
central importance in the investigation of the structure-function 
relationship of enzymes providing a major contribution to our 
understanding of the chemical events of catalysis. Information 
about the nature of reaction intermediates and transition states 
can be extrapolated to define the geometry of this site. In the 
same way the unique properties of high catalytic efficiency and 
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the decisive specificity of individual enzymes can be explained by 
the participation of several distinct functional amino acid groups 
within the active site. 
There are many different techniques which are used to locate and 
define functional groups at catalytic sites of enzymes. One of the 
most powerful is X-ray crystallography. Application of this 
method to native enzymes and enzyme-subtrate complexes can 
provide detailed three-dimensional analyses of protein stucture 
and topography. However, there are practical limitations to its 
routine use and in order to perform this expensive and time- 
consuming analysis the protein must first be available in a 
crystalline state. Questions are still raised however, as to the 
validity of models for enzymes in aqueous solutions constructed 
from these data. There are more simple procedures however, 
that can provide good preliminary information about the nature 
of the enzyme structure and action. 
(1) Substrate specificity studies examine the interaction of the 
enzyme with chemically modified substrates or inhibitors. 
(2) Chemical modification of specific amino acid residues using 
group selective reagents. 
(3) Affinity labelling using "designer" substrate analogues to 
effect specific binding. 
The aim of this chapter is to show how the technique of chemical 
modification can be usefully employed to predict what amino acid 
groups may reside at the active site of the N- 
deoxyribosyltransferase-11 enzyme. In doing so an attempt will 
be made to assign specific roles for these residues in the 
processes of binding and glycosyl transfer. 
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4.2 CHEMICAL MODIFICATION 
Chemical modification of an enzyme involves the covalent binding 
of a chemical reagent to an amino acid side chain in the enzyme. 
Modification is usually accompanied by a change in the enzyme, 
often observed as a fall in the enzyme activity. This loss is seen if 
an 'essential' residue is blocked, if substrate binding is sterically 
impeded or if the conformation of the native protein has been 
altered leading to a distortion of the active site pocket. Ideally 
the loss of activity should be seen as a result of selective binding 
of a reagent to a single amino acid or amino acid type in 
conditions where conformational perturbations arising from the 
effects of the reagent are kept to a minimum. 
Only those amino acids with polar side-chains are usually 
receptive to these modifying agents and their reactivity is 
primarily a function of their nucleophilicity. Residues with 
reactive side-chains can be classified into those with acidic 
moieties (aspartate & glutamate), basic groups (arginine, histidine 
& lysine), polar, uncharged side-chains (cysteine, serine & 
tyrosine), and those amino acids with reactive moieties on their 
side-chains (methionine & tryptophan) [126,127]. 
In practice the selectivity of the reagents is not absolute and 
reaction can occur with more than one type of residue. 
Modification affecting non-essential amino acid residues not 
directly involved in catalysis or in the binding and recognition of 
ligands can result in loss of activity due to conformation changes 
to the enzyme. Therefore, careful assessement of results must be 
made before the assignment of roles to any residues suspected of 
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catalytic participation. However, diligent application of this 
technique to probe the active site can provide a great deal of 
information in the initial stages of mechanistic interpretation. 
Further information can be gained by performing these 
modifications in the presence or absence of substrates or 
inhibitors of the enzyme and monitoring their affect on the 
velocity and degree of modification. These compounds can act as 
protecting agents, masking vunerable amino acid side chains from 
the effect of modifying reagents. The exploitation of certain 
requirements and properties of these reactions such as their pH 
dependence and the ability to reverse selected modifications to 
recover altered biological activity also enables more detailed 
analysis. An example of this type is seen with the base- mediated 
reversal of the diethyl pyrocarbonate modification of histidyl 
groups, where hydroxylamine can be used to displace the 
carbethoxy group from the covalent carbethoxy-imidazole 
complex (Figure 4.1) 
0+00 N .. -C ý'ýC2H5 + HO-C-C2H5 HN Nl.. X/ N+0(C- CA) 2 HN X 
+0 
HN N --- C -- C2H, 5 
NH26H 
SAS 
HN 
sllý// 
N 
0 
11 
H2NO -C- CA 
Figure 4.1 
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There are a number of variables arising from the influence of the 
protein environment which can affect the reactivity of certain 
functional groups. Enzymes possess microenvironments where 
functional groups may exhibit reactivities quite different from 
those expected for side chains of isolated amino acids. The active 
site is such a niche and commonly this results in groups at the 
site with widely different pKa values to those predicted and this 
situation provides the means to take advantage of the pH 
dependence of most modification reactions. Most of the reactions 
are carried out at or around the pKa of the target group where 
the best selectivity can be achieved. Hydrogen bonding can act to 
stabilise species to either enhance or depress group reactivity and 
the protein matrix can lower the rate of certain reactions by 
providing protection from the reagent. 
In practice the native enzyme is incubated with a large excess of 
a group-specific reagent over that of the protein concentration in 
conditions suitable to the reactivity of the target residue and the 
enzyme stability. At intervals, aliquots of the reaction mixture 
are removed and assayed under standard assay conditions for 
enzyme activity. 
Despite extensive investigations of the kinetic mechanism of the 
transfer reactions of N-deoxyribosyltransferases, very little work 
has been carried out to examine the nature of the precise groups 
involved in catalysis. Uerkvitz [89] demonstrated that when 
deoxyribosyltransferase from L. helveticus was treated with the 
sulphydryl modifying reagents, p-chloromercuribenzoate and 
iodoacetamide, no reduction in enzyme activity was observed and 
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thus deduced that residues with thiol groups in the enzyme were 
not essential for the transfer activity. 
Outlined below are the methods chosen for the specific chemical 
modification of selected amino acids. 
4.2.1 CHEMICAL MODIFICATION REACTIONS EMPLOYED 
4.2.1.1 Modification ot Arginine Groops 
The highly basic guanidium group of arginine is usually modified 
by condensation with dicarbonyl compounds [128]. The majority 
of procedures employ reagents like 1,2-cyclohexanedione (CHD), 
[129,1301 2,3, -butanedione or phenylglyoxal [1311. The 
phenylglyoxal reaction is irreversible and can be performed 
under mild conditions in alkaline media. The derivative contains 
two phenyglyoxal moieties per guanidium group. The F--amino 
groups of lysine are also susceptible to modification under these 
conditions, but react slowly compared to arginine groups. The 
products of this reaction can be reversed by incubation with 
hydroxylamine. 
The guanidium group of arginine residues can also condense with 
1,2-cyclohexanedione at pH 8-9 in sodium borate buffer. 
Reaction in this buffer favours the production of a single, stable 
product (Figure 4.2). 
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Figure 4.2 
In strong alkali, a single derivative, CHD-arginine is formed. At 
pH 7-8 the reaction also produces a single product DHCH-arginine 
[130]. Arginyl residues can be regenerated from DHCH-arginine 
by incubation in hydroxylamine at neutral pH. 
4.2.1.2 Modification of Carboxyl Groups 
Most methods for the modification of carboxyl groups in proteins 
involve the use of water-soluble carbodiimides [132,133]. These 
react with carboxyl moieties at acidic pH to generate an activated 
0-acylisourea intermediate. There are two possible routes of 
reaction for this intermediate: rearrangement to generate an N- 
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acylurea via intramolecular acyl transfer, or reaction with a 
nucleophile to yield the acyl-nucleophile product plus urea 
(Figure 4.3). It has been demonstrated that if the reaction 
mixture contains a high concentration of the nucleophile, the path 
to rearrangement is virtually abolished [134,135]. Side reactions 
can occur with tyrosyl [136] and sulphydryl [1371 groups. 
Tyrosyl modification can be slowly reversed with hydroxylamine 
but sulphydryl groups require protection prior to carbodiimide 
treatment. An advantage of this method is the two stage nature 
of the reaction, allowing greater versatility towards varying 
reactants and conditions. Carbodiimides do have some practical 
limitations in these reactions including their instablility in 
aqueous solution [138] and a tendency to cause some proteins to 
polymerize [1391. The use of a very strong attacking nucleophile 
has been used to good effect in lessening the degree of 
polymerization [1391. 
Isoxazolium salts are also used to determine the presence of 
carboxyl groups [140,141,142]. The reagent N-ethyl-5- 
isoxazolium-Y-sulphonate or Woodward's Reagent-K (WRK), has 
been used in a number of different modifications reactions with 
proteins both alone, and in conjunction with carbodiimides to 
demonstrate the existence of two different functional carboxyl 
groups [1431. 
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The active species in this reaction is thought to be a highly 
reactive intermediate ketoketenimine [140,142] (Figure 4.4). A 
method has been developed so that the progress of the reaction 
can be followed spec trophotometric ally [144]. However, 
Woodward's Reagent-K is not without its problems as a modifying 
agent, one of its major limitations being that it is very unstable 
above pH 3 [140, 142]. 
4.2.1.3 Modification ot Tryptophan Groups 
The modification of tryptophan residues usually employ oxidative 
methods whereby the indole moiety is transformed to the 
oxindole group (Figure 4.5). The generation of a significantly 
weaker chromophore enables the oxidation to be followed 
spectrophotometric ally by monitoring the decrease in absorbance 
at 280nm and allows quantiative analysis of the modification. N- 
bromosuccinimide (NBS) [145] is often the reagent of choice but 
is so reactive that it remains somewhat unselective and side 
reactions include peptide bond cleavage in addition to the 
oxidation of tyrosine, methionine, cysteine, histidine and arginine 
side-chains. Thus, modification by this method must be 
interpreted with some caution. 
CH3 H CH3 
NBS 
H0 
NN 
HH 
Figure 4.5 
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Other reagents for modifying tryptophan side chains include alkyl 
and benzyl halides. 2-Hydroxy-5-nitrobenzyl bromide (HNB-Br) 
or Koshland's reagent-1, is known to react rapidly and selectively 
over a wide range of pH with tryptophan residues [146,147, 
1481. The m echanism by which this reagents works is complex 
and a number of products can be generated from its reaction with 
tryptophan groups in a protein. The primary reaction is thought 
to involve the formation of a 1: 1 adduct across the 3-position of 
the indole ring, but the final products seem to depend on the 
nature of the groups in the neighbourhood of the tryptophan 
which is being modified [149]. 
4.2.1.4 Modification ot Lysine Groups 
2,4,6-Trinitrobenzenesulphonate (TNBS) is used under alkaline 
conditions to facilitate the modification of e, -amino groups [150, 
15 1J (Figure 4.6). 
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Imidoesters such as ethylacetimidate (1) are also used around at 
high pH to modify amino groups [152]. 
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4.2.1.5 Modification of Cysteine Groups 
The high degree of reactivity of the thiol groups on cysteine 
residues has permitted the design of a number of modification 
agents. Among these are a few which are selective and which 
react rapidly under mild conditions [1531. p- 
Chloromercuribenzoate (p-CMB) [154,155] and N-ethylmaleimide 
(NEM) [153,156], are often the reagents of choice. Reaction of 
thiol groups in proteins with these reagents gives rise to spectral 
changes which enables the modification reaction to be easily 
followed and quantified. Thi ol groups can be readily regenerated 
from mercaptide deriv atives produced by their reaction with 
organomercurials. 
The reagent N-ethylmaleimide exhibits good specificity towards 
cysteine residues at neutral pH and generates stable thiol esters. 
The reaction is readily quantified due to the change in spectral 
characteristics on the formation of the adduct (Figure 4.7). 
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4.2.1.6 ModiEtcation of Tyrosine Residues 
Nitration using tetranitromethane (TNM) is the usual approach to 
modifying tyrosyl groups on proteins [157,158,159]. This highly 
selective reagent attacks the phenol group of the side chain in 
alkaline media to produce the 0-nitrotyrosine. This proceeds 
under very mild conditions and the extent of modification can be 
monitored s pec troph otometric ally since the 0-nitrophenolate 
anion absorbs maximally at 428nm. Polymer formation due to 
crosslinking of peptides has be found to be a problem with some 
proteins despite mild conditions and strict control of the 
concentration of reagent used [160,1611. 
4.2.1.7 Modiftation ot Histidine Groups 
The imidazole group of histidine has traditionally been modified 
by photo-oxidation in the presence of oxygen and a 
photosensitive dye such as methylene blue or Rose Bengal [162, 
163]. The mechanism of the reaction is complex and evidence 
points to a number of possible reactive species. However, this is 
not a selective method and a variety of amino acids are 
susceptible to photoxidation including methionine, cysteine, 
tryptophan and tyrosine in addition to histidine. Some degree of 
specificity can be gained by control of the pH of the medium [1641 
and choice of photos en sitizin g dye [162,165]. At neutral pH 
histidine is the most likely to undergo oxidation. In acidic media 
methionine, cysteine and tryptophan are all subject to oxidation. 
That the choice of dye is an important determinant for specific 
reaction has been demonstrated with the high selectivity of Rose 
Bengal for histidine residues as compared to methylene blue and 
other dyes. 
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Diethyl pyrocarbonate has also been used widely as a histidine- 
acylating agent for proteins [166-1691. When used near neutral 
pH, it has a high specificity for the imidazole group of histidine 
residues. The progress of the reaction can be followed by the 
increase in absorbance at 240nm due to the formation of the 
carbethoxyhistidyl group (Figure 4-1). Biological activity can be 
restored by incubating the modified protein with a nucleophile 
such as hydroxylamine [168]. DEPC is however, unstable in 
aqueous media, especially at high pH [1701. 
4.3 KINETICS OF THE N-DEOXYRIBOSYLTRANSFERASE 
REAMON 
To elucidate the mechanism of an enzyme reaction it is essential 
to delineate the reaction pathway, determining the sequence and 
nature of these processes and the rates at which they proceed; 
this includes the detection and characterization of reaction 
intermediates. 
Of those two-substrate reactions which do not involve the 
formation of a ternary complex, the most important class consist 
of reactions which proceed via ping pong or enzyme substitution 
mechanisms. Kinetic studies of the purine: purine and the 
pyrimidine: purine N-deoxyribosyltransferase activities from L. 
helveticus [82,83], have shown that the enzymes transfer the 
deoxyribosyl moiety from a purine or a pyrimidine base by a 
ping-pong bi-bi mechanism (Figure 4.8). 
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There are a number of criteria laid down for the kinetic 
characterization of this type of mechanism [86], and one of the 
most important indications that enzyme substitution is operative 
can be seen when parallel lines are generated in double reciprocal 
plots for different concentrations of fixed substrates. Other 
evidence can be obtained by establishing the patterns of 
substrate and product inhibitions. Holguin showed with the 
enzymes from L. helveticus, that each product is a competitive 
inhibitor of the corresponding substrate and a non-competitive 
inhibitor of the other. Having shown that such a reaction route 
might be functional, confirmatory evidence can be obtained by (a) 
the demonstration of partial reactions (Figure 4.9): 
2'-Deoxycytidine +E E-G + Cytosine 
Where E= enzyme and E-G = Glycosyl-enzyme intermediate 
Figure 4.9 
and (b) the isolation of the modified intermediate form of the 
enzyme. 
By definition, the ping-pong bi-bi mechanism implies the 
formation of a covalent-intermediate. Kinetics can be a useful 
tool in providing evidence for intermediates, but proof is only 
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satisfied when a suspected intermediate is isolated and 
characterized. The aim of this section was to determine the 
pathway of the N-deoxyribosyltransferase reaction and to 
demonstrate the existence of a glycosyl-enzyme intermediate 
using radiolabelled 2'-deoxyribonucleo side substrate. 
4.4 EXPERIMENTAL PROCEDURE 
This section details the experimental procedure used to modify 
amino acid residues of N-deoxyribosyltransferase-11 from L. 
leichmannii. In all cases control experiments were carried out. 
The deoxyribosyltransferase activity was assayed under standard 
conditions. 
Modification of Ar2inine Residues. 
(A) 1,2-Cyclohexanedione 
1,2-Cyclohexanedione was recrystallized from petroleum ether. 
The reaction mixture containing 1,2-cyclohexanedione (Table 4.1) 
and enzyme in sodium borate buffer, pH 8.0, was incubated at 
371C for 2 hours. Excess reagent was removed by dialysis against 
pipes buffer, pH 6.5 at 40C, and the dialysate assayed for 
transferase activity. 
(B) Phenylglyoxal 
This modifying reaction was carried out in the same way as 
described for 1.2-cyclohexanedione. 
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Modification of Carboxvl Residues. 
(A) Carbodiimide 
The modification was carried out according to the method of 
Carraway and Koshland [132]. The reaction mixture contained 
lOmM glycine methyl ester, 1-(3 -dimethylaminopropyl)-3 -ethyl 
carbodiimide, (Table 4.1) and the enzyme in phosphate buffer, pH 
4.75. Samples were removed, diafiltered through a 
Microcentricon 10,000 filtration apparatus and the retentate 
assayed for N-deoxyribosyltransferase activity. 
(B) Woodward's Reagent-K 
Because of the instability of the reagent above pH 3, a fresh 
solution was made for each individual reaction. The modification 
was carried out in phosphate buffer, pH 7.9 at 25'C. Aliquots 
were taken at intervals and excess reagent removed by 
centrifugation through Sephadex G-25. The eluant fraction was 
assayed for enzyme activity. 
Modification of Tryptophan Residues. 
(A) 2-Hydroxy-5-nitrobenzyl bromide (Koshland's Reagent-I) 
The reagent, dissolved in L, 4-dioxane, was added to the reaction 
mixture containing the enzyme in citrate phosphate buffer, pH 
4.0. This was incubated at 251C, for 40 minutes and the excess 
reagent removed by a passage through Sephadex G-25, before the 
eluant was assayed for activity. 
*Due to the high molecular weight of the protein it was taken that all activity would be 
eluted from the column. Control experiments supported this assumption. 
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Modification of Lysine Residues. 
(A) Ethylacetimidate. HCI 
The enzyme was incubated with ethylacetimidate. HCI in buffer, 
pH 8.5 at 250C for 2 hours. The reaction was stopped by the 
addition of 5-fold ammonium acetate, and excess reagent 
removed by centrifugation through a 1CM3 Sephadex G-25 
column. The filtrate was assayed for N-deoxyribosyltransferase 
activity. 
(B) 2,4,6,, -Trinitrobenzenesulphonate 
The TNBS reagent was recrystallized according to the method of 
Fields [151]. The reaction mixture containing TNBS and enzyme 
in phosphate buffer, pH 8.0, was held at 251C for 3 hours. 
Aliquots were taken every 30 minutes and passed through 
Sephadex G-25 before assaying for activity. 
Modification of Cvsteine Residues. 
(A) p-Chloromercuribenzoate 
Stock solutions of p-chloromercuribenzoate were prepared in 
OAM pipes buffer, pH 7.0, and OAM sodium acetate buffer, pH 
4.6, according to the method of Riordan and Vallee [153] and the 
concentrations determined by the change in absorbance 
233nm 
on the addition of cysteine. The enzyme was 
incubated at pH 7.0 
and 4.6 at 251C for 2 hours. These solutions were then passed 
through Sephadex G-25 and the activity of the eluant 
determined. 
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(B) N-Ethylmaleimide 
The reaction was carried out in pipes buffer, pH 7.0 at 37'C for 2 
hours and passed through Sephadex G-25 before the extent of 
modification was determined. 
Modification of Tvrosine Residues. 
Stock solutions of tetranitromethane were made up freshly in 
95% ethanol. The modification reaction was initiated by the 
addition of TNM to a solution of the enzyme in phosphate buffer, 
pH 7.8, and the mixture kept at 251C for 40 minutes. Aliquots 
were removed at intervals and immediately assayed for activity. 
The concentration of ethanol did not exceed 5% (v/v) in the 
reaction mixture. 
(B) N-Bromosuccinimide 
The was performed under the same conditions as described for 2- 
hydroxy-5-nitrobenzyl bromide. Aliquots from the reaction 
mixture were removed at intervals, quenched with 5-fold L- 
tryptophan and the extent of modification determined by the 
standard enzyme assay. 
Modification of Histidine Residues. 
(A) Photoxidation. 
Rose Bengal (Table 4.1) was incu bated with the enzyme in 0.05M 
phosphate buffer, pH 7.0. The re action mixture was held at 250C 
for 16 minutes at a distance of 20cm in front of a 1000 watt 
tungsten lamp whilst oxy gen was gently bubbled over the surface 
of the solution. Aliquots (100ýtl) were withdrawn at intervals and 
passed through a column (lCM3) of Sephadex G-25* . The eluant 
III 
fraction was assayed for activity according to the standard 
procedure. The control reaction was performed in the dark with 
the same concentration of Rose Bengal. 
(B) D iethylpyro carbonate. 
The DEPC was freshly diluted with ice-cold ethanol (95%) before 
each experiment. The concentration of the reagent was 
determined from the increase in absorbance at 240nm after 
reaction with lOmM imidazole, pH 7.5, where E3,20OM-1cm--1 
The reaction was initiated by the addition of the DEPC to the 
enzyme in 0.05M pipes buffer, PH 6.5. This was incubated for 8 
minutes at 22'C. The concentration of ethanol in the reaction 
mixture did not exceed 5% (v/v). Control experiments containing 
enzyme, buffer and ethanol, equivalent - to that used to add DEPC, 
demonstrated it had no effect on enzyme activity during the time 
course of the reaction. Aliquots were removed from the reaction 
mixture at intervals and quenched with 0.01M L-histidine. The 
extent of modification was determined by measuring the enzyme 
activity. 
Kinetic measurements. 
All kinetic measurements were carried out according to the 
standard HPLC assay. 
Detection of a Glvcosvl-Enzvme Intermediate using Radiolabelle 
Thmidine. 
Specific activity of 51-3H thymidine: 15.2 Ci/mmol. 
16gl 513H thymidine added per ml protein. (41gg/ml. ) 
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The incorporation of radioactive reagent was determined by 
coprecipitating 20.5gg of labelled N-deoxyribosyltransferase-Il 
with 150gg bovine serum albumin (BSA) in ice-cold 10% (w/v) 
trichloroacetic acid (TCA). After the addition of the TCA the 
protein was allowed to precipitate at OOC. The resulting 
precipitate was collected on GF/C microglass fibre filters and 
washed with a further 20-40ml of ice-cold 10% TCA. The filter 
was then air dried and the collected precipitate solubilized from 
the GF/C filter by incubating in I. Oml of NCS tissue solubilizer 
overnight at room temperature or at 550C for 2 hours. The 
radioactivity was measured by scintillation counting in 9ml 
econofluor scintillation fluid. Glacial acetic acid (35gl) was added 
to quench chemiluminescence. Control experiments were 
performed to eliminate the effects of non-specific binding of the 
labelled substrate to the BSA. The counting efficiency was 
determined by the addition of a 3H20 internal standard. 
In the first experiment only native enzyme was coprecipitated 
with BSA and the solution left for 30 minutes in TCA. In the 
second experiment, in addition to the native enzyme (a), 20.5 gg 
of the N-deoxyribosyltransferase-II was heat-treated prior to 
labelling (b). It was kept at 850C for 30 minutes then cooled to 
room temperature before use. 
4.5 RESULTS AND DISCUSSION 
4.5.1 GLYCOSYL-ENZYME INTERMEDIATE 
In the results from the kinetic experiments it was observed that a 
double reciprocal plot in the transfer reaction between adenine 
and 2'-deoxycytidine generated parallel lines (Figure 4.10). 
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When both of these substrates were present at the same 
concentrations a double reciprocal plot of initial velocity -against 
substrate concentration gave a straight line (Figure 4.11). These 
results agree with those described by Holguin for the N- 
deoxyribosyltransferase enzymes from L. helveticus [82,83], and 
confirm that the ping-pong bi-bi mechanism is operative. 
Radiolabellinp- Experiment. 
Exiveriment 1. 
Incorporation = 1.12% or O. Olmoles 5'-3H Thd*/mole protein 
Experiment 2. 
Incorporation (a) 5.6% or . 0056moles 51-31-1 Thd*/mole protein 
Incorporation (b) 3.1% or . 0031moles 51-311 
Thd*/mole protein 
The rational behind this method was to establish by the 
incorporation of radioactivity, us ing 5'-[3H] thymidine. the 
existence of a covalent glycosyl enzyme intermediate in the 
transfer of 2 -deoxyribosyl moiety by N-deoxyribosyltransferase- 
II. The mech anism of this transfer reaction has been described in 
L. helveticus, [83] but this has been a purely kinetic approach and 
experiments to show that a glycosyl enzyme participates 
in the 
transfer have not been attempted. Reasonable support for the 
presence of such an intermediate is provided by these results. 
*Thymidine. 
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Figure 4.10 
Initial velocity pattern for the (dC->A) reaction 
with N-deoxyribosyltransferase-Il, with adenine 
as the varying substrate. 
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Figure 4.11 
Initial velocity pattern for identical 
concentrations of substrates 2'-deoxycytidine 
and adenine. 
115 
ww %J w luu I 
l/Adenine (mM) 
When the thymidine is radiolabelled exclusively in the 51 -position 
of the deoxyribose group and incubated without an acceptor base, 
it would be expected that any incorporation of radioactivity into 
the protein would be due to the formation of a cov alently- bound, 
glycosyl-enzyme intermediate. In the first experiment, an 
incorporation of 1.12% or O. Olmoles 51_3H thymidine/mole 
protein was recorded. Repeat of the procedure with native and 
heat-treated enzyme, under slightly altered reaction conditions, 
showed a 5-fold increase in incorporation of the labelled 
thymidine into the native enzyme. The heat-treated enzyme 
demonstrated an incorporation of 3.1%, 55% of that of the native 
enzyme under the same conditions. This diminution of 
incorporation was attributed to the partial denaturation of the 
enzyme by heat treatment, and lend further support to the 
hypothesis of the covalent glycosyl-enzyme intermediate. The 
covalent nature of the enzyme is assumed because of the TCA 
step in the procedure. In the second experiment the reactions 
conditions were also adjusted to reduce the duration of the TCA 
precipitation. The incorporation of radioactivity rose by 80% 
suggesting that the glycosyl-enzyme is acid labile. 
These preliminary experiments provide reasonable support for 
the existence of the glycosyl intermediate postulated by kinetics. 
That this is clearly a glycosyl- rather than a nucleoside-enzyme 
intermediate, needs to be corroborated by dual labelling 
experiments. Attempts to radiolabel this enzyme with [14C]-base- 
and [3H]-sugar-labelled nucleosides should show the exclusive 
incorporation of tritium. Verification of its existence could be 
obtained by its isolation. However, there are often problems 
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associated with this procedure, the most common being the 
stability of the intermediate form. 
In his study of the formation of 2'-deoxynuc leo sides from 8- 
substituted purines by nucleoside deoxyribosyltransferase from 
L. leichmannii, Huang found that in certain instances both the 3- 
and the 9-(2'-deoxyribofuranosyl) nucleosides were formed [871. 
In the case of the transfer reaction between thymidine and 8- 
bromoadenine, however, it was observed that prolonged 
incubation of the reaction mixture with the enzyme resulted in 
the decrease of the 3 -(2'-deoxyrib of uranosyl) nucleoside 
concentration and an increase in the 9-(2'-deoxyribofuranosyl) 
product. In the absence of this enzyme no interconversion was 
observed. Significant amounts of hydrolysis were also found to 
occur in the presence of the N-deoxyribosyltransferase, because 
of the long time of reaction (Figure 4.12). This hydrolysis was 
proportional to the concentration of enzyme and suggests the 
hydrolysis of a deoxyribosyl intermediate form. The presence of 
the 2'-deoxyribose was detected by the diphenylamine assay 
procedure [109]. 
1 17 
Thymidine 
EE 
Thymine Thymine 
H20 
Deoxyribosyl-enz., an, E+ deoxyribose 
8-Br-Ade 8, -Br-Ade 
E- Br-Ade 
EE 
Figure 4.12 
Huang also demonstrated that these rates of hydrolysis were 
independent of the nature of the purine base. These results point 
toward the existence of a glycosyl intermediate in the transfer 
reaction mediated by this enzyme, (Figure 4.12). 
Evidence of a sugar-enzyme intermediate has also been 
confirmed by kinetic and selective labelling methods in the 
glycosyl transfer enzyme, sucrose phosphorylase [1711. In this 
instance, the intermediate was found to be extremely unstable at 
neutral pH and proved hard to isolate. If the complex can be 
isolated, it must be demonstrated that this modified form of the 
enzyme is able to act as a kinetically competent intermediate in 
the transfer reaction (Figure 4.13). 
Adenine 2-deoxyadenosine 
Enzyme-Glycosyl 
Figure 4.13 
Enzyme 
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An investigation of the exact configurational state of the 
intermediate by nmr should also aid in the definition of the 
transfer mechanism. However, large amounts of material are 
required to perform this task. 
Isolation in a stable form also extends the possibility of 
segregating the active site peptide. Information about the 
sequence of this fragment could provide information on the 
amino acids at or near the active site which participate in binding 
and catalysis. 
4.5.2 CHEMICAL MODIFICATION 
It can be observed (Table 4.1) that a number of the modification 
reactions had little or no effect on the original activity of the 
enzyme. Treatment with the sulphydryl reagents N- 
ethylmaleimide and p -chloromercuri ben zoate, caused no 
significant decrease in activity. This is in agreement with 
Uerkevitz [89] who reported that sulphydryl reagents had no 
effect on deoxyribosyltransf erase activity of L. helveticus. 
Similarly, specific reagents directed against lysine and arginine 
residues had little effect upon the original activity. Thus, these 
residues obviously play no direct role in either binding 
substrates, catalysis or stabilization of the active site pocket. 
N-Bromosuccinimide reduced the activity of the enzyme to a 
substantial degree but when a second tryptoph an -specific 
reagent, 2-hydroxy-5-nitrobenzyl bromide was employed 
in the 
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modification reaction, there was virtually no loss of activity, 
suggesting tryptophan is not a catalytically important residue. As 
N-bromosuccinimide is known to be a highly reactive and 
somewhat unselective reagent, the partial inactivation of the 
enzyme observed in this case may be due to conformational 
changes from peptide cleavage, rather than modification of an 
essential amino acid function. 
The most pronounced inactivation is observed when histidyl, 
carboxyl and tyro syl -specific agents are used. The reaction were 
observed to follow pseudo-first-order kinetics over a range of 
concentrations. To support the observations that essential 
imidazole and carboxyl groups might participate in catalysis, two 
different modifying reagents were used to examine each case. 
When treatment of the N-deoxyribosyltransferase with Rose 
Bengal caused a diminution in activity (Figure 4.14), the theory 
that there might be an essential histidine residue was 
substantiated by the use of the selective agent, DEPC which was 
observed to have the same effect of reducing the activity (Figure 
4.15). In each case, when the concentration of the modifying 
agent was increased, the rate of inactivation increased. 
Indications that an important carboxyl residue may reside in or 
near the active site were given by the observation that there is a 
loss of activity from the reaction of carbodiimide with the N- 
deoxyribosyltransferase (Figure 4.16). This too was supported by 
using a second carboxyl- specific reagent, the isoxazolium salt, 
Woodward's Reagent-K, which reduced transferase activity 
significantly (Figure 4.17). 
121 
110 
100 
90 
80 
70 
60 
50 
40 
Rose Bengal 
Rose Bengal Protection 
Ix. 
0 
0 10 
Time (minutes) 
Figure 4.14 
20 
Inactivation of N-deoxyribosyltransferase-11 by 
Rose Bengal in the presence and absence of 
2'-deoxycytidine (50mM). Reaction performed 
in phosphate buffer, pH 7.0,25C. 
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Figure 4.15 Time (minutes) 
inactivation of N-deoxyribosyltransferase-Il by DEPC- 
Reaction performed in 50mM pipes buffer, pH 6.0,22C. 
Reaction quenched with IOMM L-histidine. 
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Inactivation of N-Deoxyribosyltransferase-II by 
1-(3-Dimethylaminopropyl)3-ethyl-carbodiimide, 
in the presence and absence of 2'-deoxycytidine (50mM). 
Reaction mixture performed in phospahte buffer, pH 4.75,25C. 
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Inactivation of N-Deoxy ri bosy I trans ferasc -11 with 
Woodward's Reagent-K. Reaction performed 
in phosphate buffer, pH 7.9,25C. 
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Further reactions carried out in the presence of the natural 
nucleoside substrate 2'-deoxycytidine demonstrated that certain 
modifications could be significantly retarded. This held for the 
inactivations by histidyl (Figure 4.18) and carboxyl reagents 
(Figure 4.16) but not for the modification with tetranitromethane 
(Figure 4.19). 
Lack of protection of the enzyme with high concentrations of 
substrate from the tetranitromethane reagent suggest that a 
tyrosine residue is not involved in any direct action at the active 
site. It is possible however, is that a non-essential tyrosine may 
play an auxiliary role in stabilization or binding close to the active 
site. Alternatively, TNM may be inducing a change in tertiary 
structure, causing the peptides to crosslink and the protein to 
precipitate, bringing about a reduction in overall activity. 
The observations that both the histidyl and carboxyl 
modifications reactions are able to be arrested by the inclusion of 
high concentrations of substrate in the reaction mixture, is 
consistent with their importance in catalysis. The modification by 
DEPC is normally able to be reversed by incubating the treated 
enzyme with high concentrations of hydroxylamine, at neutral pH 
for long periods of time. This displacement of the carbethoxy 
group from the modified histidine lends further support to the 
idea that it is a histidine that is being selectively modified, and 
that diminution of activity is not due to either conformational 
perurbations or the modification of another residue. Many 
proteins, however, remain sensitive to this nucleophile and in the 
case of the DEPC-induced modification of N- 
deoxyribosyltransferase-II, it was not possible to show any 
reaction reversal. 
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Figure 4.18 Inactivation of N-Deoxyribosyltransferase-II 
by DEPC in the presence and absence 
of 2'-deoxycytidine (50mM). 
Reaction conditions as described in text. 
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Inactivation of N-Deoxyribosyltransferase-11 with 
TNM in the presence and absence of 
2-deoxycytidine (50mM). Reaction 
performed in phosphate buffer, pH 7.8,25C. 
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The protection that 2'-deoxycytidine conveyed was not complete 
in most of the reactions. In the Rose Bengal and the DEPC 
substrate protection experiments, the modification was reduced, 
on average between 20-30%. In the reaction of the enzyme with 
Woodward's Reagent-K, protection was only 25%. This incomplete 
protection could be due to the weak binding of the substrate in 
the vicinity of these groups at the active site, or modifications 
may be occuring at positions where the protein interaction with 
the substrate is not maximal. Modification in the presence of a 
pyrimidine or purine base alone or a combination of base and 
nucleoside was found not to increase protection. Ideally a strong 
binding, reversible inhibitor is required for full protection of 
vunerable active site residues. The 2'-deoxycytidine did, 
however, give complete protection to the enzyme from 
carbodilmide, which indicates that this reagent 
modifying a different carboxyl residue to the 
Reagent-K. 
Kinetics of Modification 
might be 
Woodward's 
When the enzyme (E) reacts with an inhibitor (I) it may do so in 
a number of ways. It can bind irreversibly, (a), to the protein, 
reversibly, (b), or via the formation of an intermediate complex, 
Ei, (c). 
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For the reversible reaction the forward reaction rate (v) can be 
expressed as: 
v=k1[E][IJ. (d) 
and where the concentration of I is much greater than the 
concentration of E, 
ki [I] or kobs = ki [I] 
Discriminations between the three mechanisms is possible by 
plotting kobs as a function of the inhibitor concentration. 
The rate constants measured over the first 8 minutes for the 
inactivation of the deoxyribosyltransferase with DEPC shows that 
there is a non-linear dependence of the observed rate constant on 
the DEPC concentration (Figure 4.20). The pseudo-first-order rate 
constants were calculated from slopes of linear inactivation 
curves over a range of concentrations of DEPC. 
Analysis of the data suggests that it fits the model of (c) and that 
an intermediatery reversible complex is formed between the 
acylating DEPC and an imidazole group on the enzyme prior to 
covalent modification. 
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Assuming that the equilibrium condition k2 << k_1 holds [172],, it 
can be shown that: 
kobs kjk2lll 
kl[l] + k-I 
A plot of kobs versus [1] (Figure 4.20) gives a rectangular 
hyperbola. 
The reciprocal of equation (f) gives : 
1-1+ Kdiss 1 (h) 
ro-b 
sk2 k2 I 
II Kdiss 
When Fo-b 
s versus 
T- , the slope 
is equal to k2 . and the intercept 
I 
on the y-axis to --Iý-2. (Figure 4.21). 
Thus Kdiss = 8.7 x 10-5. 
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Figure 4.20 Plot of equation (f) for the inactivation 
of N-Deoxyribosyltransferase-II with DEPC. 
Reaction conditions as described in text. 
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Figure 4.21 Dependence of the pseudo-first-order rate 
constant, kobs, for the inactivation of 
N-Deoxyribosyltransferase-Il on DEPC 
concentration. Conditions as described in text. 
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Knowledge of the substrate requirements for correct binding and 
orientation, the enzyme substitution mechanism, the existence of 
a glycosyl-enzyme intermediateg and the conclusion that two 
specific residues are central to catalysis, allow the construction of 
several models. These models illustrate the sequence and nature 
of the transfer reaction of N-deoxyribosyltransferase-II based on 
the aforementioned results and conclusions. Since there is an 
overall retention of configuration, there are two possible 
mechanisms by which the transfer of the glycosyl group could 
occur. Firstly via an SNI reaction, where the intermediate form is 
a carboniurn ion (Figure 4.22). Here, the expulsion of the base 
from the donor nucleoside could be mediated by an unionized 
acid residue, while the enzyme -c arboniu m ion intermediate is 
stabilized by electrostatic interactions with an ionized acid group. 
However, since there is reasonable evidence for a covalent 
glycosyl-enzyme intermediate in the mechanism, it is unlikely 
that the reaction would proceed via the carboniurn ion form. In 
the second case, the transfer might proceed by two successive SN2 
steps such that the glycosyl intermediate has an (x-configuration 
about the C-1 glycosidic bond. The nature of the ping-pong bi-bi 
mechanism indicates a covalently bound intermediate 
participates in the reaction scheme we have shown evidence to 
suggest that this is likely to be the case in N- 
deoxyribosyltransferase-II. The glycosyl moiety could become 
attached to groups on one of the two residues postulated to exist 
at the active site; the imidazole group of a histidine residue or 
tthe carboxyl group of an acidic residue. Figures 4.23 and 4.24 
depict what might happen in the glycosyl transfer between a 
pyrimidine nucleoside and a purine base. In the first case (Figure 
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4.24), it is envisaged that a histidine acts as a nucleophile, 
generating the glycosyl-enzyme intermediate on the release of 
the pyrimidine base. A second base then displaces this sugar 
moiety by the reverse reaction. Two additional residues with 
acid groups act as proton donors and acceptors in this push-pull 
reaction. It is possible that there are two distinct carboxyl groups 
mediating in this transfer which might react differently to 
distinct modifying agents. This could explain this different 
degrees of protection observed for the carbodiimide and 
isoxazolium salt modifications respectively. In the second case 
(Figure 4.24), the glycosyl group is attached to the carboxyl of an 
acid residue. Examples of this are seen in the enzymes (x - 
galactosidase and P-galactosidase. 
What is unclear at the moment is exactly which of the residues 
postulated as being crucial to catalysis, participates at each stage 
of the reaction mechanism. Confirmation of these hypotheses will 
require further detailed studies to clarify the role of each group 
at any point in the transfer. 
The acquisition of a strong inhibitor would greatly aid in this 
process, enabling quantitative modification to be carried out with 
radiolabelled reagents. Knowledge of the substrate specificity 
should also enable the synthesis of an affinity label. The design 
of a purine inhibitor or affinity label would allow the active sites 
of both N-deoxyribosyltransferase-I and -Il to be scrutinized in 
detail. Both of these enzymes have very similar pH profiles 
which is an initial indication that they may possess similar 
catalytic groups at the binding site. What is likely to differ is the 
residues which secure the shape of the binding pocket and 
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Figure 4.22 
Possible Model for Enzymatic Reaction of N-Deoxyribosyltransferase-II 
involving two carboxyl groups 
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Figure 4.24 
Possible Model for Enzymatic Reaction of N-Deoxyribosyltransferase-11 
involving a histidine and a carboxyl group 
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determine the specificity between these two N- 
deoxyribosyltransferases. Many of these modification agents are 
unstable in aqueous solution [1701 and away from extremes of pH 
the degree of inactivation achieved was not always as high as 
anticipated, and strict conditions were often required to preserve 
the stability of the reagents and enzyme. An affinity label may 
obviate the need for many of these problems to be solved. 
Uridine phosphorylase from E. coli has been shown to be 
sensitive to the reagent DEPC and inactivation of the enzyme 
indicates that there is an essential histidine residue at the active 
site [ 1731. The phosphorylase mechanism is known to proceed 
via the formation of an phosphate-oc-l-ribose intermediate. It is 
possible that there is a covalent enzyme-ligand complex bound 
through a histidine residue similar to the one postulated for N- 
deoxyribosyltransferase-II from L. leichmannii. 
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